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Dr. E . Stanley Crawford died in Houston, Texas, on October 27,1992. Dr. Charles Dubost, 
in attendance a few years ago at a surgical meeting in the United States, said that his real 
reason for coming to America was to pay his usual visit to "the greatest surgeon in your 
country." When pressed for his name, Dubost said, "Stanley Crawford." 
Born in Evergreen, Alabama, on May 12, 1922, Stanley Crawford was a brilliant cardio-
vascular surgeon whose workload throughout his life was staggering, in spite of which his 
results were exemplary and set a standard for the rest of us to follow. While his early and 
richly rewarding writings stressed the drama of the domain in which he worked, in his later 
years his publications became precise and analytical. They too, in a different way, were rich-
ly rewarding to their readers. The perceptible transition was just one of the many remarkable 
and totally admirable characteristics of this lovable, gifted man. The readership of T H E 
JOURNAL OF T H O R A C I C AND CARDIOVASCULAR S U R G E R Y surely joins the Editor in his 
loneliness for this productive, provocative, and genuinely unique and wonderful surgeon. 
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Hemostatic activation during cardiopulmonary 
bypass with different aprotinin dosages in pediatric 
patients having cardiac operations 
The effect of high-dose aprotinin treatment on hemostatic activation during cardiopulmonary bypass in 
pediatric patients having cardiac operations was investigated. Sixty patients weighing less than 10 kg 
undergoing cardiac operations for different types of congenital heart diseases were studied: 20 patients 
were treated with aprotinin 2 x 15,000 K I U / k g , 20 patients with 2 X 30,000 K I U / k g , and 20 patients 
without aprotinin treatment served as the control group. Different split products of fibrinogen and/or 
fibrin and the fibrinolytic activity on fibrin plates were measured to assess fibrinolytic activation. F 1 / F 2 
prothrombin fragments, thrombin-antithrombin Ill-complex, and fibrin monomers were measured to 
estimate thrombin activation. There was a significant dose-dependent reduction in fibrin-fibrinogen split 
product formation during cardiopulmonary bypass: In the high-dose aprotinin group the concentration 
of the split products at the end of bypass was 1.5 ± 0.6 Mg/ml, compared with 3.4 ± 3.0 Mg/ml in the 
low-dose aprotinin group and 6.7 ± 3.5 ßg/ml in the control group (p < 00.5). Fibrinolytic activation 
on fibrin plates was also significantly reduced by aprotinin. Fibrin monomer formation was significantly 
diminished at the end of cardiopulmonary bypass in the high-dose group: 9.2 ± 5.2 Mg/ml compared 
with 21.6 ± 14 jug/ml in the control group (p < 00.5). Elastase in complex with ai-protease inhibitor 
at the end of bypase was increased to the same amount in the three groups: 784 ± 278 ng/mL (control 
group), 693 ± 189 ng/ml (low-dose aprotinin), and 719 ± 270 ng/mL (high dose aprotinin) (no 
significant difference). Blood loss 6 hours postoperatively was significantly (p < 00.5) less in the 
high-dose group (99 ± 32 ml/m 2 ) than in the control group (164 ± 87 ml/m 2 ; low-dose group: 
160 ± 106 ml/m 2 ). These observations suggest an attenuation of hemostatic activation during cardio-
pulmonary bypass with less plasmin formation and, because of inhibition of contact activation, less 
thrombin generation with aprotinin treatment. Thus the thrombotic-thrombolytic equilibrium is kept 
more balanced after cardiopulmonary bypass. High-dose aprotinin treatment is recommended for 
pediatric patients undergoing cardiac operations. (J THORAC CARDIOVASC SURG 1993;105:712-20) 
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tion is caused by an attenuation of the hemostatic 
activation during cardiopulmonary bypass (CPB). 
Although it is generally accepted that impaired platelet 
function is the most important factor of postoperative 
bleeding9 and that platelet function is better preserved 
with aprotinin,10"12 the precise mechanism underlying the 
action of aprotinin is still being discussed: A direct plate-
let protective effect,12 inhibition of fibrinolysis,2,13 and 
inhibition of the contact phase of coagulation4 are con-
sidered to be the main mechanisms of aprotinin action. 
However, there is strong evidence supporting the hypoth-
esis that the inhibition of kallikrein and the resulting 
attenuation of contact phase activation is one important 
aspect of aprotinin action. 
All these studies have been performed on adults hav-
ing cardiac operations. With respect to coagulation, there 
are important differences between adults and infants or 
neonates: The vitamin K-dependent coagulation factors 
(II, VII , IX, and X ) are lower in newborns and attain 
adult levels between 2 and 12 months of age.14 The bio-
logic activity of the contact factors (factor XI , factor XII , 
prekallikrein, high-molecular-weight kininogen) is de-
pressed to variable degrees.15 These differences are more 
pronounced in immature infants or infants with cyanotic 
heart disease than in adults. Data were published about 
the effect of a lower dosage of aprotinin on blood loss in 
repair of congenital heart defects.16 However, no data are 
available in the literature so far concerning the impact of 
high-dose aprotinin on the coagulation system in infants 
and children. 
The aim of the present study was to investigate the 
influence of different aprotinin dosages on the activation 
of hemostasis during CPB in pediatric patients having 
cardiac operations. 
Methods 
After institutional approval, 60 pediatric patients with a body 
weight less than 10 kg, undergoing cardiac operations for 
different congenital lesions, were enrolled in the protocol. 
Patients were excluded from the study if the expected duration 
of CPB exceeded 120 minutes. Patients were randomly assigned 
to one of three groups, each consisting of 20 patients. To twenty 
patients (group L , low-dose protocol) an aprotinin bolus of 
15,000 kallikrein-inhibiting units per kilogram (KIU/kg) (Bay-
er AG, Leverkusen, Germany) was given after induction of 
anesthesia and an additional bolus of 15,000 KIU/kg was add-
ed to the pump prime of the heart-lung machine. In the high-
dose aprotinin group (group H) 20 patients received an aproti-
nin bolus of 30,000 KIU/kg after induction of anesthesia and 
the same dose was given to the pump prime. The control group 
(group C) consisted of 20 patients without aprotinin treatment. 
Anesthesia. Premedication consisted of morphine 0.2 mg/ 
kg, flunitrazepam 0.04 mg/kg, and atropine 0.01 mg/kg given 
1 hour before induction of anesthesia. For induction, halothane 
was applied via a face mask (0.5 to 1.0 vol %). Neuromuscular 
blockade was achieved and maintained with pancuronium (0.1 
mg/kg). Fentanyl (10 to 20 Mg/kg) and flunitrazepam (0.02 
mg/kg) were given to deepen and maintain anesthesia. Patients' 
lungs were ventilated to mild hypocapnia with an air-oxygen 
mixture or 100% oxygen. After intubation an arterial catheter 
(radial artery) and a central venous line were inserted via the 
right internal jugular vein. 
CPB. Mucosa heparin (375 U/kg, La Roche, Basle, Swit-
zerland) was injected via the central venous catheter before 
aortic cannulation. The extracorporeal circuit consisted of a 
bubble oxygenator (High Flex D 700 S, Dideco, Mirandola, 
Italy), nonocclusive roller pumps, and polyvinyl tubing. Blood 
from the operating field was aspirated by the cardiotomy suc-
tion and reinfused to the oxygenator via a 40 /* filter (Dideco D 
742). The oxygenator was primed in all patients with 500 ml 
homologous blood and 100 to 300 ml of crystalloid solution. 
Heparin 3000 U was added to this homologous blood unit. Two 
different techniques were applied: (1) Patients operated on with 
the aid of hypothermia were cooled during bypass to a rectal 
temperature of 26° C . The blood flow was kept to 2.4 L/min 
/m 2 , being reduced under hypothermia to 1.2 L/min/m 2 . (2) 
For deep hypothermic circulatory arrest (DHCA), patients 
were cooled until the rectal temperature was 20° C. Then per-
fusion was stopped and the venous cannula was removed from 
the right atrium. After the surgical procedure, the venous can-
nula was inserted again and the patients were rewarmed on CPB 
by means of the heat exchanger of the heart- lung machine and 
a warming blanket. 
CPB was terminated in all patients when a rectal tempera-
ture of 32° C was attained. After completion of CPB, residual 
heparin was neutralized with protamine chloride in a ratio of 1.5 
mg/125 U heparin (protamine; La Roche, Basle, Switzerland). 
One unit of fresh whole blood was available after CPB for all 
patients from which, depending on hemoglobin value and 
hemodynamics, different amounts were given. Mechanical ven-
tilation was continued for at least 12 hours after the operation. 
Blood samples. Blood samples were taken from the radial 
artery or, during CPB, from a port of the oxygenator at the fol-
lowing times: (1) after induction of anesthesia before aprotinin 
infusion, (2) 5 minutes after the onset of CPB, (3) 30 minutes 
after the onset of CPB or, in case of DHCA 15 minutes after 
the end of circulatory arrest, (4) at the end of CPB, and (5) at 
the end of the operation. After the first 5 ml of blood was dis-
carded, blood was drawn into ethylenediaminetetraacetic acid 
tubes for assessment of hematocrit value, platelet count, and 
leukocyte count or into acid-citrate-dextrose (ACD) solution 
(4:1) for all other measurements. The A C D blood was centri-
fuged at 3000g for 10 minutes at room temperature and the 
plasma was separated from the cellular components. All plas-
ma samples were frozen immediately at - 4 0 ° C in aliquots and 
thawed only before testing. 
Aprotinin plasma concentrations were quantified by means of 
a competitive enzyme-linked immunosorbent assay according to 
Müller-Esterl and associates.17 The split products of the cross-
linked fibrin were measured by two independent immunoassays, 
based on monoclonal antibodies to D-dimers (Boehringer, 
Mannheim, Germany) and to fibrin (Organon Teknika, Heidel-
berg, Germany). The degradation products of fibrinogen, the 
total degradation products (Organon Teknika, Heidelberg, 
Germany), the complex of thrombin with antithrombin III 
(Behringwerke, Marburg, Germany), F1/F2 prothrombin 
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Table I . Demographic data on patients 
Operation time CPB time CCHD DHCA 
Group Age (days) Weight (gm) (min) (min) (yes/no) (yes/no) 
Control 211 ± 189 5477 ± 1838 168 ± 57 84 ± 31 10/10 14/6 
Low dose 263 ± 189 6178 ± 1934 200 ± 47 100 ± 27 9/11 13/7 
High dose 349 ± 305 6313 ± 2479 187 ± 47 98 ± 4 0 6/14 10/10 
CPB, Cardiopulmonary bypass; CCHD, cyanotic congenital heart disease; DHCA, deep hypothermic circulatory arrest. 
Table I I . Preoperative diagnoses 
Control Low dose High dose Total 
VSD 6 1 8 15 
T G A * 5 3 3 11 
C A VSD 1 5 5 11 
PA 3 1 2 6 
T O F 1 2 1 4 
SV 2 1 0 3 
TA P VR 0 2 0 2 
TA 0 2 0 2 
T A C 1 1 0 2 
other 1 2 1 4 
Total: 20 20 20 60 
VSD, Ventricular septal defect; TGA, transposition of the great arteries; CA VSD, 
complete artrioventricular septal defect; PA, pulmonary atresia; TOF, tetralogy 
of Fallot; SV, single ventricle; TAPVR, total anomalous pulmonary venous return; 
TA, tricuspid atresia; TAC, truncus arteriosus communis. 
*Only atrial level repairs. 
fragments (Behringwerke, Marburg, Germany), and elastase in 
complex with ai-protease inhibitor (E. Merck, Darmstadt, 
Germany) were determined by sandwich enzyme-linked immu-
nosorbent assays using polyclonal and monoclonal antibodies. 
The concentration of fibrin monomers was measured by an 
immunoassay using monoclonal antibodies directed against the 
N-terminal a-chain of human fibrin (Boehringer, Mannheim, 
Germany). 
Spontaneous fibrinolytic activation in the native samples and 
in their euglobulin fraction was estimated by the use of plasmi-
nogen containing human fibrin plates.18 Any development of a 
lysis area, regardless of its size, was considered to be an indica-
tion of extrinsic plasminogen activator(s) in the sample. The 
activated clotting time was determined according to the instruc-
tions of the manufacturer (Hemochron 400, International 
Technidyne Corp., Edison, N.J.). For global coagulation tests, 
routinely applied clotting methods were used. Blood loss 
through the chest tubes was measured in the intensive care unit 
6, 12, and 24 hours after the operation. Because body weight 
varied substantially among patients, the blood loss was ex-
pressed as a function of the body surface area in milliliters per 
square meter. 
Data analysis. Two-way analysis of variance was used to 
analyze normal distributed data. Whenever appropriate, signif-
icant differences among the three groups were explored with the 
Newman-Keuls test. Parametric data were given as mean 
± standard deviation. If Shapiro's test of normality revealed 
that data did not conform to a normal distribution, comparison 
among the three groups was done with the Kruskal-Wallis test. 
The x 2 test was used for categoric data. Stepwise multiple 
regression analysis was performed to assess the independent 
contributions of group allocation, cyanotic heart disease, or the 
application of D H C A to changes of hemostatic variables at the 
end of CPB. Linear regression analysis was applied to examine 
the relationship between the temperature 30 minutes after onset 
of CPB and the degree of fibrin formation and the concentra-
tion of the total degredation products. A p value less than 0.05 
was considered statistically significant. 
Results 
All 60 patients admitted to the study were included to 
the subsequent analysis. Table I shows the demographic 
data for the three groups and Table II the preoperative 
diagnoses. No significant differences were found for any 
of the variables. The mean CPB times including circula-
tory arrest times were 84 ± 31 minutes (group C), 
100 ± 27 minutes (group L ) , and 98 ± 40 minutes 
(group H), respectively. Fourteen (group C), 13 (group 
L ) , and 10 patients (group H) were operated on in 
DHCA. The circulatory arrest time was 34 ± 17 minutes 
in group C (n = 14) compared with 48 ± 17 minutes in 
group L (n= 13) and 55 ± 12 minutes in group H 
(n = 10) (p < 0.05, group C versus groups L and H). The 
mean CPB time, not including the arrest time for all 
infants with DHCA (n = 37), was 56 ± 25 minutes, 
whereas the CPB time was 81 ± 38 minutes in patients 
without DHCA (n = 23) (p < 0.05). 
The highest aprotinin plasma concentrations were 
measured 30 minutes after the onset of CPB: 73 ± 30 
KIU/ml in group Land 99 ± 25 KIU/ml in group H. At 
the end of CPB the concentrations were 63 ± 72 K I U / 
ml (group L ) and 92 ± 20 KIU/ml (group H), respec-
tively. Patients of group L received a total amount of 
98,000 ± 42,000 K I U aprotinin, as compared with 
180,000 ± 81,000 K I U in group H (p < 0.05). 
The concentration of the F1/F2 prothrombin frag-
ments and the thrombin-antithrombin III complex 
increased steadily during CPB. At the end of the opera-
tion the F l /F2 concentrations were 9.9 ± 4.9 ng/ml 
(group C), 11.2 ± 4.8 ng/ml (group L ) , and 6.3 ± 6.0 
ng/ml (group H) (p < 0.05 versus groups C and L ) . In 
contrast, the thrombin-antithrombin III complex did not 
show significant differences. The course of the concentra-
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group C • group L • 
group H • 
before 
p < 0.05 vs Control 
op end 
Fig. 1. Fibrin monomer concentration increased during CPB 
in all three groups. However, the increase in the high-dose 
aprotinin group (group H) was significantly attenuated by 
aprotinin. This indicates reduced clotting activation with apro-
tinin treatment. 
tion of fibrin monomers is given in Fig. 1. The level was 
significantly higher in the control group (21.6 ± 14 
jug/ml) than in groups L and H (12.2 ± 10and9.2 ± 5.2 
/xg/ml, respectively) (p < 0.05 versus group C) . There 
was a significant correlation between the formation of 
fibrin monomers and the concentration of aprotinin in the 
plasma at the end of CPB (Fig. 2). 
The course of the concentration of fibrin-fibrinogen 
split products is given in Fig. 3. Aprotinin showed a dose-
dependent effect on the development of split products. At 
the end of CPB the concentrations of fibrin-fibrinogen 
split products were 6.7 ± 3.5 ßg/m\ in group C, 
3.4 ± 3.0 ßg/m\ in group L , and 1.5 ± 0.6 ßg/ml in 
group H (p < 0.05). The course of the concentration of 
D-dimers was nearly identical (D-dimer concentrations 
at the end of the operation: 1.2 ± 0.8 ^g/ml, group C; 
0.9 ± 0.9 fig/m\, group L ; and 0.5 ± 0.4 jug/ml, group 
H) (p < 0.05 versus group C). The fibrin split products 
paralleled the course of the D-dimers (Fig. 4). Thirty 
minutes after the onset of CPB, the fibrin plates showed 
positive results in 75% of patients in group C, in 65% in 
group L , and in 35% in group H (the lysis areas were 
15.8 ± 20.1 mm2,8.7 ± 8.5 mm2, and 1.7 ± 3.8 mm2in 
groups C, L , and H, respectively; p < 0.05). There were 
no differences in the results on the fibrin plates at the end 
of CPB or the end of the operation. 
No significant correlation could be found between rec-
tal temperatures measured 30 minutes after onset of CPB 
and the formation of fibrin or fibrin degradation products. 
However, there was a tendency in all three groups toward 
a higher degree of activation of coagulation and fibrinol-
ysis with lower body temperatures. Multivariate analysis 
,16x + 23,5, r 2 = ,18 
K group H 
9 group L 
30 40 50 60 70 80 90 100 110 [KIU/ml] 
aprotinin plasma concentration end of CPB 
Fig. 2. Correlation of aprotinin plasma concentration at the 
end of CPB and fibrin monomer concentration. The higher the 
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group H • 
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* p < 0.05 vs Control 
Fig. 3. The total split products of fibrinogen and fibrin (FSP) 
demonstrated a dose-dependent reduction during CPB with 
aprotinin treatment. This indicates less fibrinolytic activity with 
aprotinin treatment. 
identified only the group allocation as being independent-
ly associated with a decreased clotting activation at thJ 
end of extracorporeal circulation. However, regardless of 
group allocation, all patients operated on in DHCA 
showed at the end of CPB increased concentrations of 
fibrin-fibrinogen split products (with DHCA, 4.6 ± 3 . 8 
Mg/ml; without, 2.7 ± 2.2 /xg/ml; p = 0.05) and fibrin 
split products (with DHCA, 2.7 ± 2.9 jug/ml; without, 
1.2 ± 1.4 Mg/ml; p < 0.05) compared with patients with-
out DHCA. On the other hand, there were no differences 
in regard to hemostatic activation between cyanotic and 
acyanotic patients. 
A continuous increase of the concentration of the com-
plex bound elastase over CPB time was noted. At the end 
of CPB these concentrations were 784 ± 278 ng/ml 
(group C), 693 ± 189 ng/ml (group L ) , and 719 ± 270 
7 1 6 Dietrich et al 





Control Low Dose High Dose 
D-dimers 
221 
Control Low Dose High Dose 
* p < 0.05 vs Control 
Fig. 4. Concentrations of different split products of fibrinogen or fibrin at the end of CPB. D-dimers and split prod-
ucts of fibrin (FbDP) were measured by different immunoassays. Total degradation products (FSP) are the split 
products of fibrin and fibrinogen, whereas fibrinogen degradation products (FgDP) were determined by monoclonal 
antibodies against fibrinogen split products. There was a dose-dependent reduction of all split products at the end 
of CPB, indicating reduced fibrinolytic activity with aprotinin treatment. 
ng/ml (group H) (p = NS*). The platelet count did not 
reveal significant differences among the three groups. 
From normal preoperative values the counts dropped to 
121 ± 36 X 10 9 /L (group C), 93 ± 37 X 10 9 /L (group 
L) , and 102 ± 44 X 10 9 /L (group H) at the end of the 
operation (p = NS). The preoperative hemoglobin con-
centration varied from 13.0 ± 2.3 gm/dl (group C) to 
14.1 ± 3.4 gm/dl (group L ) and 12.8 ± 2.1 gm/dl 
(group L ) (p = NS). At the end of CPB hemoglobin val-
ues were 10.6 ± 1.4gm/dl (groupC), 10.9 ± 2.0gm/dl 
(group L ) , and 10.9 ± 1.3 gm/dl (group H), respective-
Blood losses 6 hours postoperatively were 164 ± 87 
ml/m 2 (group C), 160 ± 106 ml/m 2 (group L ) , and 
99 ± 32 ml/m 2 (group H) (p < 0.05, group H versus 
group C or L ) . However, there were no significant differ-
ences in 24-hour blood losses: 294 ± 148 ml/m 2 (group 
C), 278 ± 162 ml/m 2 (group L ) , and 199 ± 67 ml/m 2 
(group H) (range, 78 to 603 ml/m 2, group C; 79 to 761 
*NS = Not significant. 
ml/m 2, group L; and 103 to 370 ml/m 2, group H). There 
were no differences in the required units of homologous 
blood among the groups. Two units of fresh whole blood 
were available for all patients. The oxygenator of the 
heart-lung machine was primed with the first unit, and 
different amounts from the second unit were given dur-
ing and after the operation. In none of the patients was a 
third unit of bank blood necessary. 
The activated clotting time was greater than 1000 sec-
onds in all groups during CPB. None of the patients 
needed additional heparin to keep the activated clotting 
time above 400 seconds. After heparin reversal by prot-
amine chloride, the activated clotting times were 
139 ± 19 seconds (group C), 135 ± 23 seconds (group 
L ) , and 136 ± 23 seconds (group H) (/? = NS). The 
times to control bleeding, that is, the intervals between 
end of CPB and thoracic closure, were between 60 ± 1 7 
minutes (group H) and 63 ± 14 minutes (group C) 
(p = NS). No side effects attributable to aprotinin were 
observed. All patients survived the early postoperative 
period. 
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Discussion 
This investigation corroborates the results of recent 
studies-2'6'19'20 on the use of high-dose aprotinin in adults 
having cardiac operations. In the present study we found 
a dose-dependent attenuation of the deleterious effect of 
CPB on hemostatic activation, as well as a reduction of 
bleeding tendency, in our group of children undergoing 
cardiac operations with aprotinin compared with the 
control group without aprotinin treatment. Duration of 
operation and CPB, as well as preoperative hemoglobin 
concentration, were comparable among the groups, thus 
rendering negligible the influence of different surgical 
procedures on hemostatic alterations. 
Several studies have shown that clotting activation and 
fibrinolysis takes place during C P B . 2 1 , 2 2 This process 
starts with the activation of factor XII (Hageman factor) 
by the initial blood contact with the unphysiologic, non-
endothelial surfaces of the circuit of the heart-lung 
machine. The contact activation with the conversion of 
prekallikrein to kallikrein launches the activation of the 
cascades systems of the body, including the intrinsic 
coagulation pathway, fibrinolysis, the classic complement 
pathway, and the kinin-kininogen system. Contact acti-
vation does not play a role in physiologic coagulation. The 
extracorporeal circuit, however, with its artificial sur-
faces, is a highly unphysiologic system. Therefore, under 
the condition of CPB contact activation contributes to the 
activation of hemostasis. Neutrophil activation takes 
place at the same time. Heparin treatment is supposed to 
inhibit only one component of this contact activation sys-
tem, the formation of fibrin. Because thrombin already 
bound to fibrin is less inhibitable by heparin,23 fibrin for-
mation and polymerization take place despite heparin 
treatment during C P B . 2 4 
Platelets are activated either by contact with unphys-
iologic surfaces25 by generated thrombin 2 6 , 2 7 or plas-
min,2 8 which are both powerful platelet stimulators.29 It 
is known that impaired platelet function is the main cause 
of bleeding after cardiac operations.30 Thus the link 
between hemostatic and platelet activation is as follows: 
Less plasmin and thrombin formation causes less platelet 
activation. This assumption is corroborated by the results 
of several studies demonstrating better preservation of 
platelet function in patients with high-dose aprotinin 
treatment.10"12 
Our study clearly proved a dose-dependent reduction in 
fibrinolytic activity with aprotinin: Patients in the high-
dose group had the lowest concentrations of fibrin-fibrin-
ogen split products, control patients the highest, and 
patients in the low-dose group had intermediate concen-
trations. The results of the fibrin plates also demonstrat-
ed less fibrinolytic activity. However, the given dosages of 
aprotinin were not able to suppress fibrinolytic activity on 
fibrin plates completely. Besides this antifibrinolytic 
effect, a less pronounced antithrombin effect was also 
evident: We found significantly less fibrin formation in the 
patient group with the highest aprotinin dosage, and the 
concentrations of the F l /F2 fragments were significant-
ly reduced at the end of the operation. However, the 
thrombin-antithrombin Ill-complex concentrations were 
not different among the three groups. With respect to 
plasma levels of complexed elastase, we did not see any 
differences in neutrophil activation, which indicates that 
clotting and fibrinolysis products play a minor role in 
neutrophil stimulation. 
Several studies have shown the antifibrinolytic effect of 
aprotinin treatment during C P B . 2 , 1 3 Aprotinin is sup-
posed to manifest its antifibrinolytic properties in plasma 
concentrations of about 50 K I U / m l , 3 1 ' 3 2 whereas kal-
likrein inhibition is achieved only with higher concentra-
tions.33 It seems to be of paramount importance that 
aprotinin not only acts as an antifibrinolytic agent but also 
inhibits thrombin generation,4'11 thus enhancing the 
anticoagulatory effect of heparin during C P B . 3 4 This is 
the pivotal difference to therapy with solely antifibrin-
olytic agents.35 
The present data show some differences compared with 
results from adult patients treated with aprotinin. Recent-
ly, a reduction of the thrombin-antithrombin Ill-com-
plex4' 1 1 and fibrin formation36 in adult patients undergo-
ing myocardial revascularization could be demonstrated. 
The difference in these findings may be based on the dif-
ferent aprotinin plasma concentrations: The peak con-
centration found in adult patients was around 300 K I U / 
m l 4 whereas in our study the peak aprotinin plasma 
concentration in the high-dose group was 99 ± 25 K I U / 
ml 30 minutes after the onset of CPB. According to the 
dosage introduced by Royston,7 Bidstrup,37 and their 
associates, adult patients received 5 to 6 X 106 K I U 
aprotinin during a cardiac operation. This represents 
approximately 60,000 KIU/kg body weight. Thus we 
calculated the dosage in the high-dose group according to 
this regimen with 2 X 30,000 KIU/kg. However, the 
relation between circulating blood volume and the pump 
prime differs when these small patients are compared 
with adults. Therefore the diluting effect of the pump 
prime is more pronounced, resulting in lower plasma 
concentrations of aprotinin during CPB. Consequently, 
the priming volume of the heart-lung machine should be 
included in the calculation of the aprotinin dosage. One 
might anticipate even more pronounced effects on hemo-
stasis at aprotinin doses closer to those achieved in adults. 
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Another difference between infants and adults was 
the prolonged activated clotting time in our pediatric 
patients. Because of the immature hemostatic system, the 
prothrombin time and the partial thromboplastin 
t ime 1 4 , 1 5 , 3 8 in neonates and infants are prolonged. Fur-
thermore, hepatic congestion with an impaired develop-
ment of clotting factors and polycythemia with imbalance 
of cellular and plasmatic hemostatic components is com-
mon in congenital heart disease.39 However, a more sim-
ple explanation for this difference may be based on the 
fact that our patients received 3000 U of additional hep-
arin per unit of homologous blood during CPB. Therefore 
these patients were heparinized more effectively, because 
the total dosage of heparin per kilogram was higher than 
in adult patients. 
A secondary result of this study was that the temper-
ature reduction did not result in reduced hemostatic acti-
vation. In contrast, patients operated on under DHCA 
showed a tendency toward higher activation of the hemo-
static system. Thus hypothermia does not seem to protect 
from activation of the hemostatic system. 
The 6-hour postoperative blood loss was significantly 
lower in the high-dose aprotinin group than in the control 
group. Because postoperative blood loss is not the main 
predictor of transfusion requirement in patients with 
congenital heart disease, the homologous blood require-
ment was not significantly different among the groups. 
Moreover, in our institution homologous blood is avail-
able only in units containing 450 to 500 ml blood. 
Regardless of their group allocation, all patients received 
different amounts from 2 units of homologous blood dur-
ing the operation and in the early postoperative period and 
therefore came into contact with the blood of two blood 
donors. However, because patients with an expected 
bypass time longer than 2 hours were excluded from the 
study (e.g., anatomic repair of transposition of the great 
arteries), we presumably deal with a bias toward lower 
intraoperative and postoperative blood loss. This exclu-
sion was done for ethical reasons, because we did not want 
to withhold aprotinin in these longer operations in which 
the blood-saving effect of this drug was clinically obvious 
before this study. In our experience, after introduction of 
routine aprotinin treatment, a dry operative field is the 
rule, whereas during the time without aprotinin, surgical 
hemostasis was often a long-lasting endeavor. 
What are the true merits of aprotinin treatment? 
Clearly, for adult patients with cardiac disease to date, 
aprotinin reduces bleeding tendency caused by C P B 4 0 , 4 1 
and thereby reduces homologous blood requirement. This 
reduction in bleeding is the consequence of better preser-
vation of the hemostatic system. The present study dem-
onstrated a statistically significant reduction of bleeding 
tendency also for pediatric patients. However, in terms of 
transfusion requirements it was clinically insignificant. 
This might be due to patient selection (patients with 
expected long bypass times were excluded) or to the set-
up of the heart-lung machine used in our institution (rou-
tine administration of 1 unit of blood to the pump prime. 
On the other hand, this study showed a significant reduc-
tion of clotting and fibrinolytic activation. Because con-
tact activation during CPB leads to stimulation of other 
cascade systems , 4 2 , 4 3 the attenuation of hemostasis found 
in this study is a favorable effect of aprotinin treatment. 
The positive effect of aprotinin could be superseded by 
possible side effects. As a foreign protein, aprotinin has 
antigenic properties resulting in antibody formation. 
Whether this formation might cause severe sequelae dur-
ing reexposure to aprotinin, which has to be anticipated 
in operations for congenital heart disease, has not yet been 
settled. Further studies will be necessary to clarify this 
issue. 
In summary, the present data suggest that high-dose 
aprotinin treatment attenuates hemostatic activation dur-
ing CPB in pediatric patients. The maintenance of a 
hemostatic equilibrium postoperatively caused by dimin-
ished clotting and fibrinolytic activity is the main effect of 
aprotinin treatment. The higher dosage of 2 X 30,000 
KIU/kg was more effective than the dosage of 2 X 15,000 
KIU/kg. Comparing these results with data gained in 
adults, one might postulate that an even higher aprotinin 
dosage would be desirable. Although it was not possible 
to demonstrate an overall saving of homologous blood in 
these small patients, the reduction of hemostatic activa-
tion and bleeding tendency is valuable. Therefore we rec-
ommend the routine use of aprotinin in pediatric patients 
having cardiac operations. 
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Bronchogenic carcinoma; see Carcinoma, bronchogenic 
Butanedione monoxime 
Effects of 2,3-butanedione monoxime in isolated hearts: protection 




Effects of fixation back pressure and antimineralization treatment 
on the morphology of porcine aortic bioprosthetic valves 
(Flomenbaum and Schoen). 1993;105:154-64 
Operative management of the calcified aorta: a practical method of 
aortic occlusion (Underwood et al). 1993; 105:377-8 (Letter) 
Calcium 
Effect of calcium and preischemic hypothermia on recovery of 
myocardial function after cardioplegic ischemia in neonatal 
lambs (Aoki etal). 1993;105:207-13 
Effects of high plasma epinephrine and Ca 2 + concentrations on 
neonatal myocardial function after ischemia (Caspi et al). 
1993;105:59-67 
Effects of hypoxia on intracellular calcium and contractility 
(Urthaler etal). 1993;105:1114-6 (Letter) 
Improved recovery of heart transplants with a specific kit of pres-
ervation solutions (Menasche et al). 1993;105:353-63 
Normocalcemic blood or crystalloid cardioplegia provides better 
neonatal myocardial protection than does low-calcium car-
dioplegia (Pearl et al). 1993;105:201-6 
Redistribution of myocardial calcium during ischemia: relation-
ship to onset of contracture (Jimenez et al). 1993;105:988-94 
Carbon dioxide 
Proton gradient during cardiac arrest: oxygenation of St Thomas* 
Hospital cardioplegic solution and carbon dioxide level 
(Ichikawa and Yamamoto) (Letter); (von Oppell) (Reply). 
1993;105:551-3 
Carbon dioxide concentration; see Blood gas analysis 
Carcinoma 
Detection of dysplasia and carcinoma in situ with a lung imaging 
fluorescence endoscope device (Lam et al). 1993;105:1035-40 
Esophagectomy with or without thoracotomy: Is there any differ-
ence? (Tilanus et al). 1993;105:898-903 
Hypotonic cisplatin treatment for carcinomatous pleuritis found at 
thoracotomy in patients with lung cancer: in vitro experiments 
and preliminary clinical results (Ichinose et al). 1993; 105: 
1041-6 
Survival of patients with carcinoma of the esophagus treated with 
combined-modality therapy (Wolfe et al). 1993;105:749-56 
Carcinoma, bronchogenic 
Cardiac operation with associated pulmonary resection\ 
(Yokoyama et al). 1993; 105:912-7 
Carcinoma, non-small cell lung 
Anterior transcervical-thoracic approach for radical resection of 
lung tumors invading the thoracic inlet (Dartevelle et al). 
1993;105:1025-34 
Surgical resection of stage II IA and stage HIB non-small-cell lung 
cancer after concurrent induction chemoradiotherapy: a South-
west Oncology Group trial (Rusch et al). 1993;105:97-106 
Cardiac anomalies, congenital; see Heart defects, congenital 
Cardiac arrest; see Heart arrest, induced 
Cardiac-derived thromboxane A2; see Thromboxane A2 
Cardiac pacing, artificial 
Clinical significance of epicardial pacing wire cultures (Hastings 
and Robicsek). 1993;105:165-7 
Experience with an implantable tiered therapy device incorporating 
antitachycardia pacing and cardioverter/defibrillator therapy 
(Mitchell et al). 1993; 105:453-63 
Cardiac stun 
Invited letter concerning: cardiac stun syndrome (Silverman). 
1993;105:374-5 (Letter) 
The reoxygenation phenomenon (Como and Samaja) (Letter); 
(Martin and Short) (Reply). 1993; 105:373-4 
Cardiac transplantation; see Heart transplantation 
Cardioplegia; see Heart arrest, induced 
Cardioplegic solutions 
A clinical trial of University of Wisconsin solution for pulmonary 
preservation (Hardesty et al). 1993;105:660-6 
Cold agglutinins and warm heart surgery (Gokhale et al). 1993; 
105:557 (Letter) 
A comparison of intracellular solutions for donor heart preserva-
tion (Hendry et al). 1993; 105:667-73 
Impaired endothelium-dependent coronary microvascular relax-
ation after cold potassium cardioplegia and reperfusion (Sellke 
etal). 1993;105:52-8 
The microvascular distribution of cardioplegic solution in the pig-
let heart: retrograde versus antegrade delivery (Gates et al). 
1993;105:845-53 
Myocardial distribution of cardioplegic solution after retrograde 
delivery in patients undergoing cardiac surgical procedures 
(Aronson etal). 1993;105:214-21 
Normocalcemic blood or crystalloid cardioplegia provides better 
neonatal myocardial protection than does low-calcium car-
dioplegia (Pearl et al). 1993;105:201-6 
The optimal glucose concentration for intermittent cardioplegia in 
isolated rat heart when added to St. Thomas* Hospital car-
dioplegic solution (Owen et al). 1993;105:995-1006 
Particle-induced coronary vasoconstriction: the need for in-line 
filtration of cardioplegic solutions (Palanzo and O'Neill) (Let-
ter); (Rosenfeldt and Munsch) (Reply). 1993;105:1118-9 
Proton gradient during cardiac arrest: oxygenation of St. Thomas* 
Hospital cardioplegic solution and carbon dioxide level 
(Ichikawa and Yamamoto) (Letter); (von Oppell) (Reply). 
1993;105:551-3 
Reply to invited letter concerning: assessment of myocardial ultra-
structure after retrograde infusion of cardioplegic solution 
(J THORAC CARDIOVASC SURG 1992;104:1745-6) (Fischer and 
Bamer). 1993;105:762-3 (Letter) 
Retrograde versus antegrade delivery of cardioplegic solution in 
myocardial revascularization: a clinical trial in patients with 
three-vessel coronary artery disease who underwent myocar-
dial revascularization with extensive use of the internal 
mammary artery (Noyez et al). 1993;105:854-63 
Ventricular function after normothermic versus hypothermic car-
dioplegia (Yau et al). 1993;105:833-44 
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Cardiopulmonary bypass 
Blood activation during neonatal extracorporeal life support (Plötz 
etal). 1993;105:823-32 
Cardiopulmonary dysfunction produced by reoxygenation of 
immature hypoxemic animals supported by cardiopulmonary 
bypass: prevention by intravenous metabolic pretreatment 
(Matheisetal). 1993;105:513-9 
Effect of cardiopulmonary bypass on systemic release of neutro-
phil elastase and tumor necrosis factor (Butler et al). 1993; 
105:25-30 
Exclusion of the placenta during fetal cardiac bypass augments 
systemic flow and provides important information about the 
mechanism of placental injury (Fenton et al). 1993; 105:502-12 
Hemostatic activation during cardiopulmonary bypass with different 
aprotinin dosages in pediatric patients having cardiac opera-
tions (Dietrich et al). 1993; 105:712-20 
Inhibition of platelet function by heparin: an etiologic factor in 
postbypass hemorrhage (John et al). 1993;105:816-22 
Interleukin-8 release and neutrophil degranulation after pediatric 
cardiopulmonary bypass (Finn et al). 1993; 105:234-41 
Reply to: neutrophil activation during cardiopulmonary bypass 
(J THORAC CARDIOVASC SURG 1992;104:1746-8) (Dreyer 
etal). 1993;105:763 (Letter) 
Reply to invited letter concerning: changes in plasma-free thyroid 
hormones during cardiopulmonary bypass (J T H O R A C C A R -
DIOVASC SURG 1992;104:526-7) (G0tzsche and Weeke). 1993; 
105:176-8 (Letter) 
Successful restoration of cell-mediated immune response after car-
diopulmonary bypass by immunomodulation (Markewitz 
etal). 1993;105:15-24 
Time-course of free radical activity during coronary artery opera-
tions with cardiopulmonary bypass (Davies et al). 1993; 105: 
979-87 
Warm versus cold blood cardioplegia—Is there a difference? 
(Matsuuraetal). 1993;105:45-51 
Cardiotomy; see Heart surgery 
Cardioversion; see Electric countershock 
Catecholamines 
Effects of high plasma epinephrine and Ca2* concentrations on 
neonatal myocardial function after ischemia (Caspi et al). 
1993;105:59-67 
The protective effect of magnesium on acute catecholamine car-
diotoxicity in the neonate (Caspi et al). 1993;105:525-31 
Cavopulmonary anastomosis; see Anastomosis, surgical 
Cell-mediated immune response; see Immunity, cellular 
Cells, immunology 
Cytoimmunologic monitoring for rejection and infection after lung 
transplantation (Schuurman etal). 1993;105:178-80 (Letter) 
Chemotherapy; see Drug therapy 
Chest; see Thorax 
Chest wall neoplasms; see Thoracic neoplasms 
Child 
Changes in plasma fibronectin in children after elective repair of 
congenital heart defects (Hackbarth etal). 1993;105:31-6 
Comparison of two aprotinin dosage regimens in pediatric patients 
having cardiac operations: influence on platelet function and 
blood loss (Boldt et al). 1993; 105:705-11 
A decade (1982 to 1992) of pediatric cardiac transplantation and 
the impact of FK 506 immunosuppression (Armitage et al). 
1993;105:464-73 
Degeneration of aortic valve allografts in young recipients (Clarke 
etal). 1993;105:934-42 
Hemostatic activation during cardiopulmonary bypass with different 
aprotinin dosages in pediatric patients having cardiac opera-
tions (Dietrich et al). 1993;105:712-20 
Interleukin-8 release and neutrophil degranulation after pediatric 
cardiopulmonary bypass (Finn et al). 1993; 105:234-41 
Intraventricular repair for Taussig-Bing anomaly (Kawashima 
etal). 1993;105:591-7 
Invited letter concerning: aprotinin use in pediatric cardiac opera-
tions (Edmunds) (Letter); (Dietrich and Mössinger) (Reply); 
(Boldt) (Reply). 1993;105:757-60 
A new video-assisted thoracoscopic surgical technique for inter-
ruption of patent ductus arteriosus in infants and children 
(Laborde et al). 1993; 105:278-80 
Pediatric lung transplantation: the years 1985 to 1992 and the clin-
ical trial of FK 506 (Armitage et al). 1993;105:337-46 
Chordae tendineae 
Left ventricular function in experimental mitral regurgitation with 
intact chordae tendineae (Hennein et al). 1993;105:624-32 
Christmas disease 
Treatment of a patient with factor I X deficiency (hemophilia B) 
with coronary bypass surgery (Scharfman et al). 1993; 105: 
765-6 (Letter) 
Circulatory arrest; see Heart arrest, induced 
Cisplatin 
Hypotonic cisplatin treatment for carcinomatous pleuritis found at 
thoracotomy in patients with lung cancer in vitro experiments 
and preliminary clinical results (Ichinose et al). 1993; 105: 
1041-6 
Coarctation of aorta; see Aortic coarctation 
Cold agglutlns; see Agglutination 
Cold blood cardioplegia; see Heart arrest, induced 
Combined modality therapy 
Survival of patients with carcinoma of the esophagus treated with 
combined-modality therapy (Wolfe et al). 1993;105:749-56 
Commissurotomy 
Long-term results of mitral commissurotomy (Scalia et al). 1993; 
105:633-42 
Completion pneumonectomy; see Pneumonectomy 
Computed tomography; see Tomography, x-ray computed 
Computer simulation 
A computer simulation of the plasma leakage through a vascular 
prosthesis made of expanded polytetrafluoroethylene (Tabata 
etal). 1993;105:598-604 
Congenital adenomatoid malformation of lung; see Cystic ad-
enomatoid malformation of lung, congenital 
Congenital heart defects; see Heart defects, congenital 
Contractile function, postischemic; see Myocardial contraction 
Coronary angiography 
A variant course of posterior descending artery (Arsiwala and Pan-
day). 1993;105:952-3 (Letter) 
Coronary artery bypass 
Aneurysm of saphenous vein graft used for aorta-coronary bypass, 
resembling an anterior mediastinal mass (Robicsek et al). 
1993;105:949-51 (Letter) 
Clinical evaluation with exercise performance in twenty patients 
who underwent coronary artery bypass grafting with both the 
gastroepiploic and internal thoracic arteries (Isomura et al). 
1993;105:1088-94 
Dilating effects of isosorbide di nitrate on diameter of internal 
thoracic artery graft (Koike and Kimura). 1993;105:1121-2 
(Letter) 
Effect of aprotinin (Trasylol) on aorta-coronary bypass graft pa-
tency (Bidstrup et al). 1993; 1C5:147-53 
The effect of coronary reoperation on the survival of patients with 
stenoses in saphenous vein bypass grafts to coronary arteries 
(Lytle et al). 1993;105:605-14 
Infusion of autologous platelet rich plasma does not reduce blood 
loss and product use after coronary artery bypass: a prospec-
tive, randomized, blinded study (Tobe et al). 1993; 105:1007-14 
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Coronary artery bypass—cont'd 
Relative risk of aortic and femoral insertion of intraaortic balloon 
pump after coronary artery bypass grafting procedures 
(Pinkard et al). 1993;105:721-8 
The right gastroepiploic artery graft: clinical and angiographic 
midterm results in 200 patients (Suma et al). 1993; 105:615-23 
Selection of patients for same-day coronary bypass operations 
(Anderson etal). 1993;105:444-52 
Thoracic wall necrosis in a patient with internal mammary-coronary 
bypass after prosthetic replacement of the thoracoabdominal 
aorta (Aebertetal). 1993;105:557-8 (Letter) 
Time-course of free radical activity during coronary artery opera-
tions with cardiopulmonary bypass (Davies et al). 1993; 105: 
979-87 
Tranexamic acid (Cyklokapron) is not necessary to reduce blood 
loss after coronary artery bypass operations (0vrum et al). 
1993;105:78-83 
Treatment of a patient with factor I X deficiency (hemophilia B} 
with coronary bypass surgery (Scharfman et al). 1993; 105: 
765-6 (Letter) 
Ventricular function after normothermic versus hypothermic car-
dioplegia (Yau et al). 1993;105:833-44 
Very small-diameter polyurethane vascular prostheses with rapid 
endothelialization for coronary artery bypass grafting (Okoshi 
etal). 1993;105:791-5 
Coronary artery-pulmonary artery fistula; see Arterio-arterial 
fistula 
Coronary circulation 
Acute isovolemic hemodilution and blood transfusion: effects on 
regional function and metabolism in myocardium with 
compromised coronary blood flow (Spahn et al). 1993; 105: 
694-704 
Coronary disease 
Retrograde versus antegrade delivery of cardioplegic solution in 
myocardial revascularization: a clinical trial in patients with 
three-vessel coronary artery disease who underwent myocar-
dial revascularization with extensive use of the internal 
mammary artery (Noyez et al). 1993;105:854-63 
Superiority of controlled surgical reperfusion versus percutaneous 
transluminal coronary angioplasty in acute coronary occlusion 
(Allen etal). 1993;105:864-84 
A variant course of posterior descending artery (Arsiwala and Pan-
day). 1993;105:952-3 (Letter) 
Coronary reoperation; see Reoperation 
Coronary reperfusion; see Myocardial reperfusion 
Coronary vasoconstriction; see Vasoconstriction 
Coronary vessel anomalies 
Total anomalous pulmonary venous drainage by double connec-
tion corrected by ascending vein and coronary sinus repair 
(van de Wal). 1993;105:367-8 (Letter) 
Coronary vessels 
Impaired endothelium-dependent coronary microvascular relax-
ation after cold potassium cardioplegia and reperfusion (Sellke 
etal). 1993;105:52-8 
Corrections 
Correction of anterior mitral prolapse: results of chordal transposi-
tion (Salati etal) (1992;104:1268-73). 1993; 105:1056 
Effect of cardiopulmonary bypass on systemic release of neutro-
phil elastase and tumor necrosis factor (Butler et al) (1993; 
105:25-30). 1993;105:1056 
Correspondence 
Letters. 1993; 105:173-88,364-78,550-62,757-67,943-53,1114-22 
Corticosteroids; see Adrenal cortex hormones 
Costs and cost analysis 
An economic analysis of heart-lung transplantation: costs, insur-
ance coverage, and reimbursement (Evans et al). 1993; 105: 
972-8 
Crawford, E.Stanley 
E. Stanley Crawford (1922-1992). 1993; 105:579 
Cryopreservatlon 
Degeneration of aortic valve allografts in young recipients (Clarke 
etal). 1993;105:934-42 
Cryosurgery 
Extensive cryoablation of the left ventricular posterior papillary 
muscle and subjacent ventricular wall: impact on mitral valve 
function and hemodynamics (Bakker et al). 1993;105:327-36 
Crystalloid cardioplegia; see Heart arrest, induced 
Culture 
Clinical significance of epicardial pacing wire cultures (Hastings 
andRobicsek). 1993;105:165-7 
Cyklokapron; see Tranexamic acid 
Cystic adenomatoid malformation of lung, congenital 
The use of "nonanatomic" pulmonary resection in infants with ex-
tensive congenital adenomatoid malformation of the lung 
(Browdieetal). 1993;105:732-6 
Cysts 
Intrathoracic meningocele (Auge and Georg). 1993;105:561-2 
(Letter) 
Cytoimmunology; see Cells, immunology 
D 
Death rate; see Mortality 
Defibrillation, electric; see Electric countershock 
Deglutition disorders 
Dysphagia lusoria (fgci et al). 1993;105:1116-8 (Letter) 
Descending aorta; see Aorta, thoracic 
Dextrans 
Evaluation of lung metabolism during successful twenty-four-
hour canine lung preservation (Date et al). 1993; 105:480-91 
Differential lung ventilation; see Respiration, artificial 
Digestive system abnormalities 
Functional foregut abnormalities in Barrett's esophagus (Stein 
etal). 1993;105:107-11 
Disease models, animal 
Improved ultrastructural lung preservation with prostaglandin E] 
as donor pretreatment in a primate model of heart-lung trans-
plantation (Higgins etal). 1993;105:965-71 
Pathogenesis of ischemic mitral insufficiency (Lianeras et al). 
1993;105:439-43 
Dobutamine 
The effects of amrinone versus dobutamine on myocardial me-
chanics and energetics after hypothermic global ischemia (Ko 
etal). 1993;105:1015-24 
Donor heart preservation; see Organ preservation 
Donor size matching; see Organ weight 
Dose-response relationship, drug 
Comparison of two aprotinin dosage regimens in pediatric patients 
having cardiac operations: influence on platelet function and 
blood loss (Boldt et al). 1993;105:705-11 
Hemostatic activation during cardiopulmonary bypass with different 
aprotinin dosages in pediatric patients having cardiac opera-
tions (Dietrich et al). 1993;105:712-20 
Double lung transplantation; see Lung transplantation 
Double outlet right ventricle 
Intraventricular repair for Taussig-Bing anomaly (Kawashima 
etal). 1993;105:591-7 
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Drug evaluation 
Should adenosine continue to be ignored as a cardioprotective 
agent in cardiac operations? (Galinanes et al). 1993;105:180-3 
(Letter) 
Drug therapy 
Surgical resection of stage I I I A and stage HIB non-small-cell lung 
cancer after concurrent induction chemoradiotherapy: a South-
west Oncology Group trial (Rusch et al). 1993;105:97-106 
Ductus arteriosus 
Patterns of ductal tissue in coarctation of the aorta in early infancy 
(van Son et al). 1993;105:368-9 (Letter) 
Ductus arteriosus, patent 
A new video-assisted thoracoscopic surgical technique for inter-
ruption of patent ductus arteriosus in infants and children 
(Laborde et al). 1993; 105:278-80 
Dysphagia lusoria; see Deglutition disorders 
Dysplasia 
Detection of dysplasia and carcinoma in situ with a lung imaging 
fluorescence endoscope device (Lam et al). 1993;105:1035-40 
E 
Echocardiography 
Myocardial distribution of cardioplegic solution after retrograde 
delivery in patients undergoing cardiac surgical procedures 
(Aronson et al). 1993;105:214-21 
Transesophageal echography as an emergency diagnostic tool for 
acute aortic dissection (De Smet et al). 1993;105:946-7 (Let-
ter) 
Economic analysis; see Costs and cost analysis 
Editorial search 
Editorial search. 1993;105:190 
Elastase; see Pancreatopeptidase 
Electric countershock 
Experience with an implantable tiered therapy device incorporating 
antitachycardia pacing and cardioverter/defibrillator therapy 
(Mitchell etal). 1993;105:453-63 
Endocarditis 
Prosthetic valve endocarditis: experience with porcine 
bioprostheses (Settetal). 1993;105:428-34 
Prosthetic valve endocarditis with ring abscesses: surgical man-
agement and long-term results (Jault et al). 1993; 105:1106-13 
Endoscopy 
Detection of dysplasia and carcinoma in situ with a lung imaging 
fluorescence endoscope device (Lam et al). 1993;105:1035-40 
Endoscopic surveillance of Barrett's esophagus: Does it help? 
(Streitz etal). 1993;105:383-8 
Endothelins 
Plasma levels of endothelin-1 and thrombin-antithrombin I I I com-
plex in patients undergoing open chest operations (Onizuka 
etal). 1993;105:559-60 (Letter) 
Endothelium, vascular 
Very small-diameter polyurethane vascular prostheses with rapid 
endothelial!zation for coronary artery bypass grafting (Okoshi 
etal). 1993;105:791-5 
Endothdium-derived relaxing factor 
Impaired endothelium-dependent coronary microvascular relax-
ation after cold potassium cardioplegia and reperfusion (Sellke 
etal). 1993;105:52-8 
Epinephrine 
Effects of high plasma epinephrine and Ca 2* concentrations on 
neonatal myocardial function after ischemia (Caspi et al). 
1993;105:59-67 
Equipment and supplies 
Detection of dysplasia and carcinoma in situ with a lung imaging 
fluorescence endoscope device (Lam et al). 1993;105:1035-40 
Experience with an implantable tiered therapy device incorporating 
antitachycardia pacing and cardioverter/defibrillator therapy 
(Mitchell etal). 1993;105:453-63 
A long-term ventricular assist system (Pierce et al). 1993; 105:520-4 
Thoracoscopic pleurectomy for treatment of complicated sponta-
neous pneumothorax (Inderbitzi et al). 1993;105:84-8 
Esophageal achalasia, surgery 
Invited letter concerning: technique for prevention of gas-
troesophageal reflux after transthoracic Heller's operation 
(Ellis) (Letter); (Gatzinsky et al) (Reply). 1993; 105:555-7 
Technique for prevention of gastroesophageal reflux after trans-
thoracic Heller's operation (Gatzinsky et al). 1993;105:553-5 
(Letter) 
Esophageal diverticulum 
Thoracic esophageal diverticula: Why is operation necessary? 
(Altorki etal). 1993;105:260-4 
Esophageal motility disorders 
Thoracic esophageal diverticula: Why is operation necessary? 
(Altorki etal). 1993;105:260-4 
Esophageal neoplasms 
Esophagectomy with or without thoracotomy: Is there any differ-
ence? (TUanus et al). 1993; 105:898-903 
Survival of patients with carcinoma of the esophagus treated with 
combined-modality therapy (Wolfe et al). 1993;105:749-56 
Transhiatal esophagectomy for benign and malignant disease 
(Orringer et al). 1993; 105:265-77 
Esophagectomy 
Esophagectomy with or without thoracotomy: Is there any differ-
ence? (Tüanus et al). 1993;105:898-903 
Lengths of different routes for esophageal replacement in a white 
population (Rakic and Djuranoviö). 1993;105:1122 (Letter) 
Transhiatal esophagectomy for benign and malignant disease 
(Orringer etal). 1993;105:265-77 
Esophagus 
Dysphagia lusoria (Igci et al). 1993;105:1116-8 (Letter) 
Survival of patients with carcinoma of the esophagus treated with 
combined-modality therapy (Wolfe et al). 1993;105:749-56 
Ewing's sarcoma; see Sarcoma, Ewing's 
Exercise test 
Clinical evaluation with exercise performance in twenty patients 
who underwent coronary artery bypass grafting with both the 
gastroepiploic and internal thoracic arteries (Isomura et al). 
1993;105:1088-94 
Expectations 
Fulfilling expectations (Fosburg). 1993;105:194-200 (Pres. 
address) 
Experimental model; see Models, theoretical 
Extracorporeal circulation 
Blood activation during neonatal extracorporeal life support (Plötz 
etal). 1993;105:823-32 
Extracorporeal membrane oxygenation 
Plasma fentanyl levels in infants undergoing extracorporeal mem-
brane oxygenation (Leuschen et al). 1993;105:885-91 
The reoxygenation phenomenon (Como and Samaja) (Letter); 
(Martin and Short) (Reply). 1993;105:373-4 
F 
Factor V 
Immunization by bovine thrombin used with fibrin glue during 
cardiovascular operations: development of thrombin and factor 
V inhibitors (Berruyer et al). 1993;105:892-7 
Redo cardiac surgery: late bleeding complications from topical 
thrombin-induced factor V deficiency (Cmolik et al). 1993; 
105:222-8 
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Factor I X deficiency; see Christmas disease 
False-negative reactions 
N2 lung cancer outcome in patients with false-negative computed 
tomographic scans of the chest (Daly et al). 1993;105:904-11 
Femoral artery 
Relative risk of aortic and femoral insertion of intraaortic balloon 
pump after coronary artery bypass grafting procedures 
(Pinkard et al). 1993; 105:721-8 
Fentanyl 
Plasma fentanyl levels in infants undergoing extracorporeal mem-
brane oxygenation (Leuschen et al). 1993;105:885-91 
Fetus 
Exclusion of the placenta during fetal cardiac bypass augments 
systemic flow and provides important information about the 
mechanism of placental injury (Fenton et al). 1993;-105:-502-12 
Fibrillation, ventricular; see Ventricular fibrillation 
Fibrin tissue adhesive 
Immunization by bovine thrombin used with fibrin glue during 
cardiovascular operations: development of thrombin and factor 
V inhibitors (Berruyer et al). 1993;105:892-7 
Fibronectins 
Changes in plasma fibronectin in children after elective repair of 
congenital heart defects (Hackbarth et al). 1993;105:31-6 
Fibrous histiocytoma; see Histiocytoma 
Filtration 
Particle-induced coronary vasoconstriction: the need for in-line 
filtration of cardioplegic solutions (Palanzo and O'Neill) (Let-
ter); (Rosenfeldtand Munsch) (Reply). 1993;105:1118-9 
Fistula, coronary artery-pulmonary artery; see Arterio-arterial 
fistula 
FK-506 
A decade (1982 to 1992) of pediatric cardiac transplantation and 
the impact of FK 506 immunosuppression (Armitage et al). 
1993;105:464-73 
Pediatric lung transplantation: the years 1985 to 1992 and the clin-
ical trial of FK 506 (Armitage et al). 1993;105:337-46 
Prolonged lung allograft survival with a short course of FK 506 
(Hirai etal). 1993;105:1-8 
FI a v ones 
Flavone improves functional recovery after ischemia in isolated 
reperfused rabbit hearts (Ning etal). 1993;105:541-9 
Fluorescence endoscopy; see Endoscopy 
Fontan operation 
Invited letter concerning: the importance of pulsatile flow when 
systemic venous return is connected directly to the pulmonary 
arteries (Jonas) (Letter); (Muster and Mavroudis) (Reply). 
1993;105:173-6 
Staged Fontan operation for complex cardiac anomalies with sub-
aortic obstruction (Di Donato et al). 1993;105:398-405 
Successful thrombectomy for thrombosis of the right side of the 
heart after the Fontan operation: report of two cases and review 
of the literature (Hedrick et al). 1993; 105:297-301 
Foregut abnormalities; see Digestive system abnormalities 
Free radicals 
Time-course of free radical activity during coronary artery opera-
tions with cardiopulmonary bypass (Davies et al). 1993; 105: 
979-87 
G 
Gastroepiploic artery; see Arteries 
Gastroesophageal reflux 
Functional foregut abnormalities in Barrett's esophagus (Stein 
etal). 1993;105:107-11 
Invited letter concerning: technique for prevention of gas-
troesophageal reflux after transthoracic Heller's operation 
(Ellis) (Letter); (Gatzinsky et al) (Reply). 1993; 105:555-7 
Technique for prevention of gastroesophageal reflux after trans-
thoracic Heller's operation (Gatzinsky et al). 1993;105:553-5 
(Letter) 
Global ischemia; see Ischemia 
Glucose 
The optimal glucose concentration for intermittent cardioplegia in 
isolated rat heart when added to St. Thomas' Hospital car-
dioplegic solution (Owen et al). 1993;105:995-1006 
Graft rejection 
Breaking of transplantation tolerance after reduction of im-
munosuppression (Wijngaard et al). 1993;105:183-4 (Letter) 
Cytoimmunologic monitoring for rejection and infection after lung 
transplantation (Schuurman et al). 1993;105:178-80 (Letter) 
Invited letter concerning: transplantation tolerance and transplan-
tation (George) (Letter); (Wijngaard et al) (Reply). 1993;105: 
184-5 
The sensitivity of transbronchial biopsy for the diagnosis of acute 
lung rejection (Tazelaar et al). 1993; 105:674-8 
Graft survival 
Degeneration of aortic valve allografts in young recipients (Clarke 
etal). 1993;105:934-42 
Effect of aprotinin (Trasylol) on aorta-coronary bypass graft pa-
tency (Bidstrup etal). 1993;105:147-53 
Mechanical durability of pulmonary allograft conduits at systemic 
pressure: angiographic and histologic study in lambs (Kadoba 
etal). 1993;105:132-41 
Prolonged lung allograft survival with a short course of FK 506 
(Hirai etal). 1993;105:1-8 
Surgical repair of type A aortic dissection by the circulatory ar-
rest-graft inclusion technique in sixty-six patients (Galloway 
etal). 1993;105:781-90 
Graham Traveling Fellowship 
Graham Taveling Fellowship. 1993;105:572-3,768,954,1123 
H 
Heart arrest, induced 
Effect of calcium and preischemic hypothermia on recovery of 
myocardial function after cardioplegic ischemia in neonatal 
lambs (Aoki etal). 1993;105:207-13 
Impaired endothelium-dependent coronary microvascular relax-
ation after cold potassium cardioplegia and reperfusion (Sellke 
etal). 1993;105:52-8 
The microvascular distribution of cardioplegic solution in the pig-
let heart: retrograde versus antegrade delivery (Gates et al). 
1993;105:845-53 
Myocardial distribution of cardioplegic solution after retrograde 
delivery in patients undergoing cardiac surgical procedures 
(Aronson etal). 1993;105:214-21 
Normocalcemic blood or crystalloid cardioplegia provides better 
neonatal myocardial protection than does low-calcium car-
dioplegia (Pearl et al). 1993;105:201-6 
The optimal glucose concentration for intermittent cardioplegia in 
isolated rat heart when added to St. Thomas' Hospital car-
dioplegic solution (Owen et al). 1993;105:995-1006 
Proton gradient during cardiac arrest: oxygenation of S t Thomas' 
Hospital cardioplegic solution and carbon dioxide level 
(Ichikawa and Yamamoto) (Letter); (von Oppell) (Reply). 
1993;105:551-3 
Recovery of postischemic contractile function is depressed by an-
tegrade warm continuous blood cardioplegia (Misare et al). 
1993;105:37-44 
Retrograde versus antegrade delivery of cardioplegic solution in 
myocardial revascularization: a clinical trial in patients with 
three-vessel coronary artery disease who underwent myocar-
dial revascularization with extensive use of the internal 
mammary artery (Noyez etal). 1993;105:854-63 
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Heart arrest, induced—cont'd 
Surgical repair of type A aortic dissection by the circulatory 
arrest-graft inclusion technique in sixty-six patients (Gallo-
way et al). 1993; 105:781-90 
Ventricular function after normothermic versus hypothermic car-
dioplegia (Yau et al). 1993;105:833-44 
Warm versus cold blood cardioplegia—Is there a difference? 
(Matsuura et al). 1993;105:45-51 
Heart-assist devices 
Experience with an implantable tiered therapy device incorporat-
ing antitachycardia pacing and cardioverter/defibrillator ther-
apy (Mitchell et al). 1993;105:453-63 
A long-term ventricular assist system (Pierce et al). 1993; 105:520-4 
Heart contractility; see Myocardial contraction 
Heart defects, congenital 
Anatomic correction of atrioventricular discordance (Yamagishi 
etal). 1993;105:1067-76 
Anatomic repair of transposition of great arteries with ventricular 
septal defect and aortic arch obstruction: one-stage versus two-
stage procedure (Planche et al). 1993;105:925-33 
Biventricular repair of hypoplastic right ventricle assisted by pul-
satile bidirectional cavopulmonary anastomosis (Muster et al). 
1993;105:112-9 
Bless the babies: one hundred fifteen late survivors of heart trans-
plantation during the first year of life (Bailey et al). 1993; 105: 
805-15 
Changes in plasma fibronectin in children after elective repair of 
congenital heart defects (Hackbarth et al). 1993;105:31-6 
A computer simulation of the plasma leakage through a vascular 
prosthesis made of expanded polytetrafluoroethylene (Tabata 
etal). 1993;105:598-604 
Exclusion of the placenta during fetal cardiac bypass augments 
systemic flow and provides important information about the 
mechanism of placental injury (Fenton et al). 1993;105:502-12 
Interleukin-8 release and neutrophil degranulation after pediatric 
cardiopulmonary bypass (Finn et al). 1993; 105:234-41 
Intraventricular repair for Taussig-Bing anomaly (Kawashima 
etal). 1993;105:591-7 
Isolated unilateral pulmonary artery agenesis (Canver). 1993; 105: 
766-7 (Letter) 
The management of severe subaortic stenosis, ventricular septal 
defect, and aortic arch obstruction in the neonate (Bove et al). 
1993;105:289-96 
A new video-assisted thoracoscopic surgical technique for inter-
ruption of patent ductus arteriosus in infants and children 
(Laborde et al). 1993;105:278-80 
Outcomes in neonatal pulmonary atresia with intact ventricular 
septum: a multiinstitutional study (Hanley et al). 1993; 105: 
406-27 
Repair of truncus arteriosus in the neonate (Hanley et al). 1993; 
105:1047-56 
Results of a policy of primary repair of truncus arteriosus in the ne-
onate (Bove etal). 1993;105:1057-66 
Results of surgical repair of congenital supra valvular aortic steno-
sis (Myers et al). 1993;105:281-8 
Staged Fontan operation for complex cardiac anomalies with sub-
aortic obstruction (Di Donato et al). 1993; 105:398-405 
Successful thrombectomy for thrombosis of the right side of the 
heart after the Fontan operation: report of two cases and review 
of the literature (Hedrick et al). 1993; 105:297-301 
Superior function of a bicuspid over a monocuspid patch for recon-
struction of a hypoplastic pulmonary root in pigs (Sievers 
etal). 1993;105:580-90 
Heart failure, congestive 
Prostaglandin Ei for patients who have both heart and lung failure 
after cardiotomy (Mayumi and Tokunaga). 1993;105:1120-1 
(Letter) 
Heart-lung transplantation 
A clinical trial of University of Wisconsin solution for pulmonary 
preservation (Hardesty et al). 1993;105:660-6 
An economic analysis of heart-lung transplantation: costs, insur-
ance coverage, and reimbursement (Evans et al). 1993; 105: 
972-8 
Improved ultrastructural lung preservation with prostaglandin Ei 
as donor pretreatment in a primate model of heart-lung trans-
plantation (Higgins etal). 1993;105:965-71 
Heart preservation; see Organ preservation 
Heart septal defects, ventricular 
Anatomic repair of transposition of great arteries with ventricular 
septal defect and aortic arch obstruction: one-stage versus two-
stage procedure (Planche et al). 1993;105:925-33 
The management of severe subaortic stenosis, ventricular septal 
defect, and aortic arch obstruction in the neonate (Bove et al). 
1993;105:289-96 
Heart septum 
Aneurysm of the membranous ventricular septum in transposition 
of the great arteries (Como et al). 1993;105:369-71 (Letter) 
Outcomes in neonatal pulmonary atresia with intact ventricular 
septum: a multi institutional study (Hanley et al). 1993; 105: 
406-27 
Heart surgery 
Prostaglandin Ei for patients who have both heart and lung failure 
after cardiotomy (Mayumi and Tokunaga). 1993;105:1120-1 
(Letter) 
Heart transplantation 
Bless the babies: one hundred fifteen late survivors of heart trans-
plantation during the first year of life (Bailey et al). 1993;105: 
805-15 
Breaking of transplantation tolerance after reduction of im-
munosuppression (Wijngaard et al). 1993;105:183-4 (Letter) 
A comparison of intracellular solutions for donor heart preserva-
tion (Hendry et al). 1993;105:667-73 
A decade (1982 to 1992) of pediatric cardiac transplantation and 
the impact of FK 506 immunosuppression (Armitage et al). 
1993;105:464-73 
Improved recovery of heart transplants with a specific kit of pres-
ervation solutions (Menasche et al). 1993;105:353-63 
Invited letter concerning: transplantation tolerance and transplan-
tation (George) (Letter); (Wijngaard et al) (Reply). 1993; 105: 
184-5 
Heart valve, transplantation 
Inhibition of adenosine deaminase and nucleoside transport: utility 
in a model of homograft cardiac valve preimplantation pro-
cessing (Abd-Elfattah et al). 1993;105:1095-105 
Heart valve prosthesis 
Clinical experience with the Omnicarbon prosthetic heart valve 
(Misawa et al). 1993;105:168-72 
Effects of fixation back pressure and antimineralization treatment 
on the morphology of porcine aortic bioprosthetic valves 
(FlomenbaumandSchoep). 1993;105:154-64 
Late results of valve replacement with the Björk-Shiley valve 
(1973 to 1982) (Orszulak et al). 1993;105:302-12 
Prosthetic valve endocarditis: experience with porcine biopros-
theses (Sett et al). 1993;105:428-34 
Prosthetic valve endocarditis with ring abscesses: surgical man-
agement and long-term results (Jault et al). 1993;105:1106-13 
Sound spectral analysis of prosthetic valvular clicks for diagnosis 
of thrombosed Björic-Shiley tilting standard disc valve pros-
theses (Sato et al). 1993;105:313-20 
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Extensive cryoablation of the left ventricular posterior papillary 
muscle and subjacent ventricular wall: impact on mitral valve 
function and hemodynamics (Bakker et al). 1993;105:327-36 
Is there an anatomic basi s for subvalvular right ventricular outflow 
tract obstruction after an arterial switch repair for complete 
transposition? A morphometric study and review (Akiba et al). 
1993;105:142-6 
Staged Fontan operation for complex cardiac anomalies with sub-
aortic obstruction (Di Donato et al). 1993;105:398-405 
Heart ventricle, right 
Intraventricular repair for Taussig-Bing anomaly (Kawashima 
etal). 1993;105:591-7 
Heller's operation; see Esophageal achalasia, surgery 
Hemodilution 
Acute isovolemic hemodilution and blood transfusion: effects on 
regional function and metabolism in myocardium with com-
promised coronary blood flow (Spahn et al). 1993;105:694-704 
Hemodynamics 
Cardiac-derived thromboxane A2: An initiating mediator of 
reperfusion injury? (Byrne et al). 1993;105:689-93 
Extensive cryoablation of the left ventricular posterior papillary 
muscle and subjacent ventricular wall: impact on mitral valve 
function and hemodynamics (Bakker et al). 1993;105:327-36 
Hemophilia B; see Christmas disease 
Hemoptysis 
Management and prognosis of massive hemoptysis: recent experi-
ence with 120 patients (Knott-Craig et al). 1993; 105:394-7 
Hemorrhage 
Comparison of two aprotinin dosage regimens in pediatric patients 
having cardiac operations: influence on platelet function and 
blood loss (Boldt et al). 1993;105:705-11 
Effect of aprotinin (Trasylol) on aorta-coronary bypass graft pa-
tency (Bidstrup etal). 1993;105:147-53 
Infusion of autologous platelet rich plasma does not reduce blood 
loss and product use after coronary artery bypass: a prospec-
tive, randomized, blinded study (Tobe et al). 1993;105:1007-14 
Inhibition of platelet function by heparin: an etiologic factor in 
postbypass hemorrhage (John et al). 1993;105:816-22 
Redo cardiac surgery: late bleeding complications from topical 
thrombin-induced factor V deficiency (Cmolik et al). 1993; 
105:222-8 
Tranexamic acid (Cyklokapron) is not necessary to reduce blood 
loss after coronary artery bypass operations (0vrum et al). 
1993;105:78-83 
Hemostatics 
Hemostatic activation during cardiopulmonary bypass with different 
aprotinin dosages in pediatric patients having cardiac opera-
tions (Dietrich et al). 1993;105:712-20 
The hemostatic effect of autologous platelet-rich plasma versus 
autologous whole blood after cardiac operations: Is platelet 
separation really necessary? (Mohr et al). 1993;105:371-3 
(Letter) 
Heparin 
Inhibition of platelet function by heparin: an etiologic factor in 
postbypass hemorrhage (John et al). 1993;105:816-22 
Hernia 
Intrathoracic stomach: presentation and results of operation (Allen 
etal). 1993;105:253-9 
Hernia, hiatal 
Transhiatal esophagectomy for benign and malignant disease 
(Orringer et al). 1993; 105:265-77 
Histiocytoma 
Pleural effusion as the first manifestation of a malignant fibrous 
histiocytoma (Garcia-Talavera et al). 1993; 105:767 (Letter) 
Histology 
Mechanical durability of pulmonary allograft conduits at systemic 
pressure: angiographic and histologic study in lambs (Kadoba 
etal). 1993;105:132-41 
Homograft cardiac valve; see Heart valve, transplantation 
Hypertension, pulmonary 
Selective pulmonary vasodilatation with inhaled nitric oxide 
(Tönz et al). 1993; 105:760-2 (Letter) 
Hypertrophy 
Staged Fontan operation for complex cardiac anomalies with sub-
aortic obstruction (Di Donato et al). 1993;105:398-405 
Hypoplastic pulmonary root; see Pulmonary artery 
Hypoplastic right ventricle; see Heart defects, congenital 
Hypothermia, induced 
Cold agglutinins and warm heart surgery (Gokhale et al). 1993; 
105:557 (Letter) 
Determinants of myocardial oxygen consumption in fibrillating 
dog hearts: comparison between normothermia and hypother-
mia (Yaku etal). 1993;105:679-88 
Effect of calcium and preischemic hypothermia on recovery of 
myocardial function after cardioplegic ischemia in neonatal 
lambs (Aoki etal). 1993;105:207-13 
Left ventricular pressure overload during postnatal development: 
effects on coronary vasodilator reserve and tolerance to hypo-
thermic global ischemia (Yamamoto and Avkiran). 1993; 105: 
120-31 
Hypothermic cardioplegia; see Heart arrest, induced 
Hypothermic global ischemia; see Ischemia 
Hypotonic solutions 
Hypotonic ci splat in treatment for carcinomatous pleuritis found at 
thoracotomy in patients with lung cancer: in vitro experiments 
and preliminary clinical results (Ich in ose et al). 1993; 105: 
1041-6 
Hypoxemia; see Anoxemia 
Hypoxia; see Anoxia 
I 
Imaging fluorescence endoscopy; see Endoscopy 
Immunity, cellular 
Successful restoration of cell-mediated immune response after car-
diopulmonary bypass by immunomodulation (Markewitz 
etal). 1993;105:15-24 
Immunization 
Immunization by bovine thrombin used with fibrin glue during 
cardiovascular operations: development of thrombin and factor 
V inhibitors (Berruyer et al). 1993;105:892-7 
Immunomodulation; see Adjuvants, immunologic 
Immunosuppression 
Breaking of transplantation tolerance after reduction of immuno-
suppression (Wijngaard etal). 1993;105:183-4 (Letter) 
A decade (1982 to 1992) of pediatric cardiac transplantation and 
the impact of FK 506 immunosuppression (Armitage et al). 
1993;105:464-73 
Invited letter concerning: transplantation tolerance and transplan-
tation (George) (Letter); (Wijngaard et al) (Reply). 1993;105: 
184-5 
Successful restoration of cell-mediated immune response after car-
diopulmonary bypass by immunomodulation (Markewitz 
etal). 1993;105:15-24 
Implantable tiered therapy device; see Heart assist devices 
In memoriam 
E. Stanley Crawford (1922-1992). 1993; 105:579 
Nina S. Braunwald (1928-1992) (Waldhausen). 1993;105:773-4 
(Obit.) 
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Infant 
Bless the babies: one hundred fifteen late survivors of heart trans-
plantation during the first year of life (Bailey et al). 1993; 105: 
805-15 
A decade (1982 to 1992) of pediatric cardiac transplantation and 
the impact of FK 506 immunosuppression (Armitage et al). 
1993;105:464-73 
Intraventricular repair for Taussig-Bing anomaly (Kawashima 
etal). 1993;105:591-7 
Invited letter concerning: aprotinin use in pediatric cardiac opera-
tions (Edmunds) (Letter); (Dietrich and Mössinger) (Reply); 
(Boldt) (Reply). 1993;105:757-60 
Invited letter concerning: cardiac stun syndrome (Silverman). 
1993;105:374-5 (Letter) 
Lung volumes, mechanics, and perfusion after pulmonary resec-
tion in infancy (Werner et al). 1993; 105:737-42 
A new video-assisted thoracoscopic surgical technique for inter-
ruption of patent ductus arteriosus in infants and children 
(Laborde et al). 1993;105:278-80 
Patterns of ductal tissue in coarctation of the aorta in early infancy 
(van Son et al). 1993;105:368-9 (Letter) 
Plasma fentanyl levels in infants undergoing extracorporeal mem-
brane oxygenation (Leuschen et al). 1993;105:885-91 
The reoxygenation phenomenon (Como and Samaja) (Letter); 
(Martin and Short) (Reply). 1993; 105:373-4 
Total anomalous pulmonary venous drainage by double connec-
tion corrected by ascending vein and coronary sinus repair 
(van de Wal). 1993;105:367-8 (Letter) 
The use of "nonanatomic" pulmonary resection in infants with ex-
tensive congenital adenomatoid malformation of the lung 
(Browdie et al). 1993;105:732-6 
Infant, newborn 
Blood activation during neonatal extracorporeal life support (Plötz 
etal). 1993;105:823-32 
Effect of calcium and pre ischemic hypothermia on recovery of 
myocardial function after cardioplegic ischemia in neonatal 
lambs (Aoki etal). 1993;105:207-13 
Effects of high plasma epinephrine and Ca 2* concentrations on 
neonatal myocardial function after ischemia (Caspi et al). 
1993;105:59-67 
Invited letter concerning: critical aortic stenosis (McKay) (Letter); 
(Freedom) (Reply). 1993;105:365-7 
Left ventricular pressure overload during postnatal development: 
effects on coronary vasodilator reserve and tolerance to hypo-
thermic global ischemia (Yamamoto and Avkiran). 1993; 105: 
120-31 
The management of severe subaortic stenosis, ventricular septal 
defect, and aortic arch obstruction in the neonate (Bove et al). 
1993;105:289-96 
Noimocalcemic blood or crystalloid cardioplegia provides better 
neonatal myocardial protection than does low-calcium car-
dioplegia (Pearl et al). 1993;105:201-6 
Outcomes in neonatal pulmonary atresia with intact ventricular 
septum: a multi institutional study (Hanley et al). 1993; 105: 
406-27 
The protective effect of magnesium on acute catecholamine car-
diotoxicity in the neonate (Caspi et al). 1993;105:525-31 
Repair of truncus arteriosus in the neonate (Hanley et al). 1993; 
105:1047-56 
Results of a policy of primary repair of truncus arteriosus in the ne-
onate (Bove et al). 1993;105:1057-66 
Infection 
Cytoimmunologic monitoring for rejection and infection after lung 
transplantation (Schuurman et al). 1993;105:178-80 (Letter) 
In situ repair of mycotic aneurysm of the ascending aorta (Pasic 
etal). 1993;105:321-6 
Infusion of autologous platelets; see Blood component transfusion 
Inhalation administration; see Administration, inhalation 
Innominate artery; see Brachiocephalic trunk 
Insufflated talc; seeTsAc 
Insurance, health, reimbursement 
An economic analysis of heart-lung transplantation: costs, insur-
ance coverage, and reimbursement (Evans et al). 1993; 105: 
972-8 
Interleukin-8 
Interleukin-8 release and neutrophil degranulation after pediatric 
cardiopulmonary bypass (Finn et al). 1993;105:234-41 
Intraaortlc balloon pumping 
Relative risk of aortic and femoral insertion of intraaortic balloon 
pump after coronary artery bypass grafting procedures 
(Pinkardet al). 1993;105:721-8 
Intracellular solutions; see Cardioplegic solutions 
Intraoperative care 
An evaluation of the role of omentopexy and of early perioperative 
corticosteroid administration in clinical lung transplantation 
(Miller et al). 1993; 105:247-52 
Intraoperative use of inhaled low-dose nitric oxide (Miller et al). 
1993;105:550-1 (Letter) 
Intraoperative complications 
Cardiopulmonary dysfunction produced by reoxygenation of 
immature hypoxemic animals supported by cardiopulmonary 
bypass: prevention by intravenous metabolic pretreatment 
(Matheisetal). 1993;105:513-9 
Intrathoracic meningocele; see Meningocele 
Intrathoracic stomach; see Stomach diseases 
Ischemia 
Effect of calcium and preischemic hypothermia on recovery of 
myocardial function after cardioplegic ischemia in neonatal 
lambs (Aoki et al). 1993;105:207-13 
Effects of 2,3-butanedione monoxime in isolated hearts: protection 
during reperfusion after global ischemia (Boban et al). 1993; 
105:532-40 
The effects of amrinone versus dobutamine on myocardial me-
chanics and energetics after hypothermic global ischemia (Ko 
etal). 1993;105:1015-24 
Effects of high plasma epinephrine and Ca concentrations on 
neonatal myocardial function after ischemia (Caspi et al). 
1993;105:59-67 
Flavone improves functional recovery after ischemia in isolated 
reperfused rabbit hearts (Ning et al). 1993;105:541-9 
Left ventricular pressure overload during postnatal development: 
effects on coronary vasodilator reserve and tolerance to hypo-
thermic global ischemia (Yamamoto and Avkiran). 1993; 105: 
120-31 
Pathogenesis of ischemic mitral insufficiency (Lianeras et al). 
1993;105:439-43 
Recovery of postischemic contractile function is depressed by an-
tegrade warm continuous blood cardioplegia (Misare et al). 
1993;105:37-44 
Warm versus cold blood cardioplegia—Is there a difference? 
(Matsuura et al). 1993;105:45-51 
Isosorbide dinltrate 
Dilating effects of isosorbide dinitrate on diameter of internal 
thoracic artery graft (Koike and Kimura). 1993;105:1121-2 
(Letter) 
Isovolemic hemodilution; see Hemodllutlon 
L 
Left ventricle; see Heart ventricle 
Left ventricular function; see Ventricular function, left 
Leiomyosarcoma 
Leiomyosarcoma of the lung (Conte and Leitner). 1993; 105:1119-
20 (Letter) 
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Letters. 1993; 105:173-88,364-78,550-62,757-67,943-53,1114-22 
Lobectomy of lung; see Lung, surgery 
Low-calcium cardioplegia; see Heart arrest, induced 
Lung, metabolism 
Changes in alveolar oxygen and carbon dioxide concentration and 
oxygen consumption during lung preservation: the mainte-
nance of aerobic metabolism during lung preservation (Date 
etal). 1993;105:492-501 
Evaluation of lung metabolism during successful twenty-four-
hour canine lung preservation (Date et al). 1993; 105:480-91 
Lung, physiology 
Physiologic evaluation of pulmonary function in the candidate for 
lung resection (Miller). 1993;105:347-52 
Lung, surgery 
Anatomic lobectomy of the lung by means of thoracoscopy: an ex-
perimental study (Kohno et al). 1993;105:729-31 
Cardiac operation with associated pulmonary resection 
(Yokoyama et al). 1993;105:912-7 
Lung volumes, mechanics, and perfusion after pulmonary resec-
tion in infancy (Werner etal). 1993;105:737-42 
The use of "nonanatomic" pulmonary resection in infants with ex-
tensive congenital adenomatoid malformation of the lung 
(Browdie et al). 1993; 105:732-6 
Lung diseases 
Differential lung ventilation: applications beyond the operating 
room (Adoumie et al). 1993; 105:229-33 
Indications, risks, and results of completion pneumonectomy 
(Gregoireetal). 1993;105:918-24 
Management and prognosis of massive hemoptysis: recent experi-
ence with 120 patients (Knott-Craig et al). 1993; 105:394-7 
Outcomes in neonatal pulmonary atresia with intact ventricular 
septum: a multiinstitutional study (Hanley et al). 1993; 105: 
406-27 
Lung failure; see Respiratory distress syndrome 
Lung neoplasms 
Anterior transcervical-thoracic approach for radical resection of 
lung tumors invading the thoracic inlet (Dartevelle et al). 
1993;105:1025-34 
Cardiac operation with associated pulmonary resection 
(Yokoyama et al). 1993; 105:912-7 
Detection of dysplasia and carcinoma in situ with a lung imaging 
fluorescence endoscope device (Lam et al). 1993; 105:1035-40 
Hypotonic cisplatin treatment for carcinomatous pleuritis found at 
thoracotomy in patients with lung cancer: in vitro experiments 
and preliminary clinical results (Ichinose et al). 1993; 105: 
1041-6 
Leiomyosarcoma of the lung (Conte and Leitner). 1993; 105:1119-
20 (Letter) 
N2 lung cancer: outcome in patients with false-negative computed 
tomographic scans of the chest (Daly et al). 1993;105:904-11 
Surgical resection of stage I I IA and stage HIB non-small-cell lung 
cancer after concurrent induction chemoradiotherapy: a South-
west Oncology Group trial (Rusch et al). 1993;105:97-106 
Lung preservation; see Organ preservation 
Lung transplantation 
Bronchial circulation after experimental lung transplantation: the 
effect of long-term administration of prednisolone (Inui et al). 
1993;105:474-9 
Changes in alveolar oxygen and carbon dioxide concentration and 
oxygen consumption during lung preservation: the mainte-
nance of aerobic metabolism during lung preservation (Date 
etal). 1993;105:492-501 
A clinical trial of University of Wisconsin solution for pulmonary 
preservation (Hardesty et al). 1993;105:660-6 
Cytoimmunologic monitoring for rejection and infection after lung 
transplantation (Schuurman etal). 1993;105:178-80 (Letter) 
Evaluation of lung metabolism during successful twenty-four-
hour canine lung preservation (Date et al). 1993;105:480-91 
An evaluation of the role of omentopexy and of early perioperative 
corticosteroid administration in clinical lung transplantation 
(Miller et al). 1993; 105:247-52 
Lung size matching for double lung transplantation based on the 
submammary thoracic perimeter: accuracy and functional re-
sults (Massard et al). 1993;105:9-14 
Pediatric lung transplantation: the years 1985 to 1992 and the clin-
ical trial of FK 506 (Armitage et al). 1993; 105:337-46 
Prolonged lung allograft survival with a short course of FK 506 
(Hirai etal). 1993;105:1-8 
The sensitivity of transbronchial biopsy for the diagnosis of acute 
lung rejection (Tazelaar et al). 1993;105:674-8 
Lung ventilation; see Respiration, artificial 
Lung volume measurements 
Lung volumes, mechanics, and perfusion after pulmonary resec-
tion in infancy (Werner et al). 1993;105:737-42 
M 
Malignant pleural effusion; see Pleural effusion 
Mammary arteries 
Retrograde versus antegrade delivery of cardioplegic solution in 
myocardial revascularization: a clinical trial in patients with 
three-vessel coronary artery disease who underwent myocar-
dial revascularization with extensive use of the internal 
mammary artery (Noyez et al). 1993;105:854-63 
A simple and versatile sling sternal retractor for internal mammary 
artery harvesting (de Andrade Vicente). 1993; 105:560-1 (Let-
ter) 
Thoracic wall necrosis in a patient with internal mammary-coronary 
bypass after prosthetic replacement of the thoracoabdominal 
aorta (Aebert et al). 1993;105:557-8 (Letter) 
Massive hemoptysis; see Hemoptysis 
Maze procedure; see Surgery, methods 
Mechanical ventilation; see Respiration, artificial 
Mediastinum 
Aneurysm of saphenous vein graft used for aorta-coronary bypass, 
resembling an anterior mediastinal mass (Robicsek et al). 
1993;105:949-51 (Letter) 
Meningocele 
Intrathoracic meningocele (Auge and Georg). 1993;105:561-2 
(Letter) 
Mesothelioma 
Mesothelioma: an incurable, nonsurgical^ treatable disease 
(Lewis) (Letter); (Rusch) (Reply). 1993;105:943-4 
Mkrovasculature; see Blood vessels 
Mitral valve 
Extensive cryoablation of the left ventricular posterior papillary 
muscle and subjacent ventricular wall: impact on mitral valve 
function and hemodynamics (Bakker et al). 1993;105:327-36 
Mitral valve insufficiency 
Annuloplasty with flexible or rigid ring does not alter left ventric-
ular systolic performance, energetics, or ventricular-arterial 
coupling in conscious, closed-chest dogs (Castro et al). 1993; 
105:643-59 
Left ventricular function in experimental mitral regurgitation with 
intact chordae tendineae (Hennein et al). 1993;105:624-32 
Pathogenesis of ischemic mitral insufficiency (Lianeras et al). 
1993;105:439-43 
Mitral valve stenosis 
Long-term results of mitral commissurotomy (Scalia et al). 1993; 
105:633-42 
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Models, theoretical 
Anatomic lobectomy of the lung by means of thoracoscopy: an ex-
perimental study (Kohno et al). 1993;105:729-31 
Left ventricular function in experimental mitral regurgitation with 
intact chordae tendineae (Hennein et al). 1993;105:624-32 
Monocuspid patch; see Bioprosthesis 
Mortality 
Clinical experience with the Omni carbon prosthetic heart valve 
(Misawa et al). 1993;105:168-72 
Muscles 
Skeletal muscle-powered ventricle: effects of size and configura-
tion on ventricular function (Oda et al). 1993;105:68-77 
Mycotic aneurysm; see Aneurysm, infected 
Myocardial contraction 
Effects of hypoxia on intracellular calcium and contractility 
(Urthaler et al). 1993; 105:1114-6 (Letter) 
Recovery of postischemic contractile function is depressed by an-
tegrade warm continuous blood cardioplegia (Misare et al). 
1993;105:37-44 
Redistribution of myocardial calcium during ischemia: relation-
ship to onset of contracture (Jimenez et al). 1993; 105:988-94 
Myocardial infarction 
Pathogenesis of ischemic mitral insufficiency (Lianeras et al). 
1993;105:439-43 
Myocardial ischemia 
Redistribution of myocardial calcium during ischemia: relation-
ship to onset of contracture (Jimenez et al). 1993; 105:988-94 
Myocardial reperfusion 
Effects of 2,3-butanedione monoxime in isolated hearts: protection 
during reperfusion after global ischemia (Boban et al). 1993; 
105:532-40 
Havone improves functional recovery after ischemia in isolated 
reperfused rabbit hearts (Ning etal). 1993;105:541-9 
Impaired endothelium-dependent coronary microvascular relax-
ation after cold potassium cardioplegia and reperfusion (Sellke 
etal). 1993;105:52-8 
Superiority of controlled surgical reperfusion versus percutaneous 
transluminal coronary angioplasty in acute coronary occlusion 
(Allen etal). 1993;105:864-84 
Myocardial revascularization 
Retrograde versus antegrade delivery of cardioplegic solution in 
myocardial revascularization: a clinical trial in patients with 
three-vessel coronary artery disease who underwent myocar-
dial revascularization with extensive use of the internal 
mammary artery (Noyez et al). 1993;105:854-63 
Myocardium 
Myocardial distribution of cardioplegic solution after retrograde 
delivery in patients undergoing cardiac surgical procedures 
(Aronson etal). 1993;105:214-21 
Normocalcemic blood or crystalloid cardioplegia provides better 
neonatal myocardial protection than does low-calcium car-
dioplegia (Pearl et al). 1993;105:201-6 
Myocardium, drug effects 
The effects of amrinone versus dobutamine on myocardial me-
chanics and energetics after hypothermic global ischemia (Ko 
etal). 1993;105:1015-24 
Myocardium, injuries 
Invited letter concerning: cardiac stun syndrome (Silverman). 
1993;105:374-5 (Utter) 
The reoxygenation phenomenon (Corno and Samaja) (Letter); 
(Martin and Short) (Reply). 1993; 105:373-4 
Myocardium, metabolism 
Acute isovolemic hemodilution and blood transfusion: effects on 
regional function and metabolism in myocardium with com-
promised coronary blood flow (Spahn et al). 1993; 105:694-704 
Determinants of myocardial oxygen consumption in fibrillating 
dog hearts: comparison between normothermia and hypother-
mia (Yaku et al). 1993; 105:679-88 
Myocardium, physiology 
Effect of calcium and preischemic hypothermia on recovery of 
myocardial function after cardioplegic ischemia in neonatal 
lambs (Aoki etal). 1993;105:207-13 
Effects of high plasma epinephrine and Ca 2* concentrations on 
neonatal myocardial function after ischemia (Caspi et al). 
1993;105:59-67 
Myocardium, ultrastructure 
Reply to invited letter concerning: assessment of myocardial ultra-
structure after retrograde infusion of cardioplegic solution (J 
THORAC CARDIOVASC SURG 1992;104:1745-6) (Fischer and 
Bamer). 1993;105:762-3 (Letter) 
N 
Necrosis 
Thoracic wall necrosis in a patient with internal mammary-coronary 
bypass after prosthetic replacement of the thoracoabdominal 
aorta (Aebert etal). 1993;105:557-8 (Letter) 
Neointima; see Blood vessels 
Neonate; see Infant, newborn 
Neoplasms 
Medical tumors of the chest wall: solitary plasmacytoma and 
Ewing's sarcoma (Burtetal). 1993;105:89-96 
Solitary bone plasmacytoma of rib presenting as a superior sulcus 
tumor (Rocco et al). 1993;105:944-5 (Letter) 
Neurofibromatosis I 
Intrathoracic meningocele (Auge and Georg). 1993;105:561-2 
(Letter) 
Neutrophils 
Effect of cardiopulmonary bypass on systemic release of neutro-
phil elastase and tumor necrosis factor (Butler et al). 1993; 
105:25-30 
Interleukin-8 release and neutrophil degranulation after pediatric 
cardiopulmonary bypass (Finn et al). 1993; 105:234-41 
Reply to: neutrophil activation during cardiopulmonary bypass 
(J THORAC CARDIOVASC SURG 1992;104:1746-8) (Dreyer 
etal). 1993; 105:763 (Letter) 
Newborn; see Infant, newborn 
Nitric oxide 
Intraoperative use of inhaled low-dose nitric oxide (Miller et al). 
1993;105:550-1 (Letter) 
Selective pulmonary vasodilatation with inhaled nitric oxide 
(Tönz et al). 1993;105:760-2 (Letter) 
Non-small cell lung carcinoma; see Carcinoma, non-small cell 
lung 
Normocalcemic blood cardioplegia; see Heart arrest, induced 
Nor moth ermic cardioplegia; see Heart arrest, induced 
Nucleosides 
Inhibition of adenosine deaminase and nucleoside transport: utility 
in a model of homograft cardiac valve preimplantation pro-
cessing (Abd-Elfattah etal). 1993;105:1095-105 
O 
Obituaries 
E. Stanley Crawford (1922-1992). 1993; 105:579 
Nina S. Braunwald (1928-1992) (Waldhausen). 1993;105:773-4 
Omentum 
An evaluation of the role of omentopexy and of early perioperative 
corticosteroid administration in clinical lung transplantation 
(Miller and DeHoyos). 1993;105:247-52 
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Omnicarbon prosthetic valve; see Heart valve prosthesis 
Organ preservation 
Changes in alveolar oxygen and carbon dioxide concentration and 
oxygen consumption during lung preservation: the mainte-
nance of aerobic metabolism during lung preservation (Date 
etal). 1993;105:492-501 
A clinical trial of University of Wisconsin solution for pulmonary 
preservation (Hardesty et al). 1993; 105:660-6 
A comparison of intracellular solutions for donor heart preserva-
tion (Hendry et al). 1993; 105:667-73 
Evaluation of lung metabolism during successful twenty-four-
hour canine lung preservation (Date et al). 1993; 105:480-91 
Improved recovery of heart transplants with a specific kit of pres-
ervation solutions (Menasche et al). 1993;105:353-63 
Improved ultrastructural lung preservation with prostaglandin Ei 
as donor pretreatment in a primate model of heart-lung trans-
plantation (Higgins et al). 1993;105:965-71 
Organ weight 
Lung size matching for double lung transplantation based on the 
submammary thoracic perimeter: accuracy and functional re-
sults (Massard etal). 1993;105:9-14 
Oxygen 
Cardiopulmonary dysfunction produced by reoxygenation of 
immature hypoxemic animals supported by cardiopulmonary 
bypass: prevention by intravenous metabolic pretreatment 
(Matheisetal). 1993;105:513-9 
Proton gradient during cardiac arrest: oxygenation of St. Thomas* 
Hospital cardioplegic solution and carbon dioxide level 
(Ichikawa and Yamamoto) (Letter); (von Oppell) (Reply). 
1993;105:551-3 
Oxygen consumption 
Changes in alveolar oxygen and carbon dioxide concentration and 
oxygen consumption during lung preservation: the mainte-
nance of aerobic metabolism during lung preservation (Date 
etal). 1993;105:492-501 
Determinants of myocardial oxygen consumption in fibrillating 
dog hearts: comparison between normothermia and hypother-
mia (Yaku et al). 1993;105:679-88 
P 
Pacing wires; see Cardiac pacing, artificial 
Pancreatopeptidase 
Effect of cardiopulmonary bypass on systemic release of neutro-
phil elastase and tumor necrosis factor (Butler et al). 1993; 
105:25-30 
Papillary muscles 
Extensive cryoablation of the left ventricular posterior papillary 
muscle and subjacent ventricular wall: impact on mitral valve 
function and hemodynamics (Bakker et al). 1993;105:327-36 
Patent ductus arteriosus; see Ductus arteriosus, patent 
Pediatrics; see Child; Infant 
Percutaneous transluminal coronary angioplasty; see Angiopla-
sty, transluminal, percutaneous coronary 
Pericardial flap; see Surgical flaps 
Pericardium 
Preliminary experimental results of a new resorbable biomaterial 
as pericardial substitute (Fradin et al). 1993;105:364-5 (Letter) 
Perimetry 
Lung size matching for double lung transplantation based on the 
submammary thoracic perimeter: accuracy and functional re-
sults (Massard et al). 1993;105:9-14 
Perioperative care; see Intraoperative care 
Placenta 
Exclusion of the placenta during fetal cardiac bypass augments 
systemic flow and provides important information about the 
mechanism of placental injuiy (Fenton et al). 1993; 105:502-12 
Plasma 
Changes in plasma fibronectin in children after elective repair of 
congenital heart defects (Hackbarth et al). 1993;105:31-6 
A computer simulation of the plasma leakage through a vascular 
prosthesis made of expanded polytetrafluoroethylene (Tabata 
etal). 1993;105:598-604 
Effects of high plasma epinephrine and C a 2 + concentrations on 
neonatal myocardial function after ischemia (Caspi et al). 
1993;105:59-67 
The hemostatic effect of autologous platelet-rich plasma versus 
autologous whole blood after cardiac operations: Is platelet 
separation really necessary? (Mohr et al). 1993;105:371-3 
(Letter) 
Infusion of autologous platelet rich plasma does not reduce blood 
loss and product use after coronary artery bypass: a prospec-
tive, randomized, blinded study (Tobe et al). 1993; 105:1007-14 
Plasma fentanyl levels in infants undergoing extracorporeal mem-
brane oxygenation (Leuschen et al). 1993;105:885-91 
Plasma levels of endothelin-1 and thrombin-antithrombin I I I com-
plex in patients undergoing open chest operations (Onizuka 
etal). 1993;105:559-60 (Letter) 
Reply to invited letter concerning: changes in plasma-free thyroid 
hormones during cardiopulmonary bypass (J THORAC CAR-
DIOVASC SURG 1992;104:526-7) (G0tzsche and Weeke). 1993; 
105:176-8 (Letter) 
Plasmacytoma 
Medical tumors of the chest wall: solitary plasmacytoma and 
Ewing's sarcoma (Burt et al). 1993;105:89-96 
Solitary bone plasmacytoma of rib presenting as a superior sulcus 
tumor (Rocco et al). 1993; 105:944-5 (Letter) 
Platelet activation 
Blood activation during neonatal extracorporeal life support (Plötz 
etal). 1993;105:823-32 
Platelet function tests 
Comparison of two aprotinin dosage regimens in pediatric patients 
having cardiac operations: influence on platelet function and 
blood loss (Boldt et al). 1993; 105:705-11 
Platelets; see Blood platelets 
Pleura 
Thoracoscopic pleurectomy for treatment of complicated sponta-
neous pneumothorax (Inderbitzi et al). 1993; 105:84-8 
Pleural effusion 
Comparison of insufflated talc under thoracoscopic guidance with 
standard tetracycline and bleomycin pleurodesis for control of 
malignant pleural effusions (Hartman et al). 1993;105:743-8 
Pleural effusion as the first manifestation of a malignant fibrous 
histiocytoma (Garcia-Talavera et al). 1993; 105:767 (Letter) 
Pleurisy 
Hypotonic cisplatin treatment for carcinomatous pleuritis found at 
thoracotomy in patients with lung cancer: in vitro experiments 
and preliminary clinical results (Ichinose et al). 1993; 105: 
1041-6 
Pneumonectomy 
Indications, risks, and results of completion pneumonectomy 
(Gregoire etal). 1993;105:918-24 
Mesothelioma: an incurable, nonsurgical^ treatable disease 
(Lewis) (Letter); (Rusch) (Reply). 1993;105:943-4 
Physiologic evaluation of pulmonary function in the candidate for 
lung resection (Miller). 1993;105:347-52 
Pneumothorax 
Thoracoscopic pleurectomy for treatment of complicated sponta-
neous pneumothorax (Inderbitzi et al). 1993;105:84-8 
Thoracoscopic stapled resection for spontaneous pneumothorax 
(Hazelrigg etal). 1993;105:389-93 
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Polytetrafluoroethylene 
A computer simulation of the plasma leakage through a vascular 
prosthesis made of expanded polytetrafluoroethylene (Tabata 
etal). 1993;105:598-604 
Polyurethan es 
Very small-diameter polyu re thane vascular prostheses with rapid 
endotheliali zation for coronary artery bypass grafting (Okoshi 
etal). 1993;105:791-5 
Porcine bioprosthesis; see Bioprosthesis 
Posterior aorta; see Aorta 
Postnatal development; see Infant, newborn 
Postoperative complications 
Invited letter concerning: technique for prevention of gas-
troesophageal reflux after transthoracic Heller's operation 
(Ellis) (Letter); (Gatzinsky et al) (Reply). 1993; 105:555-7 
Technique for prevention of gastroesophageal reflux after trans-
thoracic Heller's operation (Gatzinsky et al). 1993;105:553-5 
(Letter) 
Postoperative period 
Selection of patients for same-day coronary bypass operations 
(Anderson etal). 1993;105:444-52 
Postoperative wound infection; see Surgical wound infection 
Potassium 
Impaired endothelium-dependent coronary microvascular relax-
ation after cold potassium cardioplegia and reperfusion (Sellke 
etal). 1993;105:52-8 
Prednisolone 
Bronchial circulation after experimental lung transplantation: the 
effect of long-term administration of prednisolone (Inui et al). 
1993;105:474-9 
Preoperative care 
Cardiopulmonary dysfunction produced by reoxygenation of 
immature hypoxemic animals supported by cardiopulmonary 
bypass: prevention by intravenous metabolic pretreatment 
(Matheis et al). 1993;105:513-9 
Preservation solutions; see Organ preservation 
Presidential address 
Fulfilling expectations (Fosburg). 1993;105:194-200 
Primate model; see Disease models, animal 
Prostaglandin E l ; see Alprostadil 
Prosthesis failure 
Effects cf fixation back pressure and antimineralization treatment 
on the morphology of porcine aortic bioprosthetic valves 
(Flomenbaum and Schoen). 1993;105:154-64 
Late results of valve replacement with the Björk-Shiley valve 
(1973 to 1982) (Orszulak et al). 1993;105:302-12 
Sound spectral analysis of prosthetic valvular clicks for diagnosis 
of thrombosed Björk-Shiley tilting standard disc valve pros-
theses (Sato et al). 1993;105:313-20 
Prosthesis-related infections 
Prosthetic valve endocarditis: experience with porcine 
bioprostheses (Settetal). 1993;105:428-34 
Prosthetic valve endocarditis with ring abscesses: surgical man-
agement and long-term results (Jault et al). 1993;105:1106-13 
Protons 
Proton gradient during cardiac arrest: oxygenation of St. Thomas' 
Hospital cardioplegic solution and carbon dioxide level 
(Ichikawa and Yamamoto) (Letter); (von Oppell) (Reply). 
1993;105:551-3 
Pulmonary artery 
Invited letter concerning: the importance of pulsatile flow when 
systemic venous return is connected directly to the pulmonary 
arteries (Jonas) (Letter); (Muster and Mavroudis) (Reply). 
1993;105:173-6 
Isolated unilateral pulmonary artery agenesis (Canver). 1993; 105: 
766-7 (Letter) 
Mechanical durability of pulmonary allograft conduits at systemic 
pressure: angiographic and histologic study in lambs (Kadoba 
etal). 1993;105:132-41 
Superior function of a bicuspid over a monocuspid patch for recon-
struction of a hypoplastic pulmonary root in pigs (Sievers 
etal). 1993;105:580-90 
Tetralogy of Fallot wi th pulmonary atresia, coronary artery-
pulmonary artery fistula, and origin of left pulmonary artery 
from descending aorta: total correction in infancy (Metras 
etal). 1993;105:186-8 (Letter) 
Pulmonary atresia; see Lung diseases 
Pulmonary function tests; see Respiratory function tests 
Pulmonary hypertension; see Hypertension, pulmonary 
Pulmonary preservation; see Organ preservation 
Pulmonary resection; see Lung, surgery 
Pulmonary root 
Time course of dimension and function of the autologous pulmo-
nary root in the aortic position (Sievers et al). 1993; 105:775-80 
Pulmonary valve stenosis 
Surgical correction of a recurrent aneurysm of the ascending aorta 
simulating pulmonary stenosis (Rabajoli et al). 1993; 105:948-
9 (Letter) 
Pulmonary veins 
Total anomalous pulmonary venous drainage by double connec-
tion corrected by ascending vein and coronary sinus repair 
(van de Wal). 1993;105:367-8 (Letter) 
Pulsatile flow 
Invited letter concerning: the importance of pulsatile flow when 
systemic venous return is connected directly to the pulmonary 








Surgical resection of stage II IA and stage HIB non-small-cell lung 
cancer after concurrent induction chemoradiotherapy: a South-
west Oncology Group trial (Rusch etal). 1993;105:97-106 
Regional blood flow 
Exclusion of the placenta during fetal cardiac bypass augments 
systemic flow and provides important information about the 
mechanism of placental injury (Fenton et al). 1993; 105:502-12 
Reimbursement; see Insurance, health, reimbursement 
Relative risk; see Risk factors 
Reoperation 
The effect of coronary reoperation on the survival of patients with 
stenoses in saphenous vein bypass grafts to coronary arteries 
(Lytle et al). 1993; 105:605-14 
Indications, risks, and results of completion pneumonectomy 
(Gregoireetal). 1993;105:918-24 
Redo cardiac surgery: late bleeding complications from topical 
thrombin-induced factor V deficiency (Cmolik et al). 1993; 
105:222-8 
Reoxygenation; see Extracorporeal membrane oxygenation; Oxy-
gen 
Reperfused hearts; see Myocardial reperfusion 
Reperfusion injury 
Cardiac-derived thromboxane A2: An initiating mediator of 
reperfusion injury? (Byrne et al). 1993;105:689-93 
Respiration, artificial 
Differential lung ventilation: applications beyond the operating 
room (Adoumie et al). 1993;105:229-33 
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Respiratory distress syndrome 
Prostaglandin Ei for patients who have both heart and lung failure 
after cardiotomy (Mayumi and Tokunaga). 1993;105:1120-1 
(Letter) 
Respiratory function tests 
Physiologic evaluation of pulmonary function in the candidate for 
lung resection (Miller). 1993;105:347-52 
Retrograde cardioplegia; see Heart arrest, induced 
Revascularization; see Blood vessels 
Ribs 
Solitary bone plasmacytoma of rib presenting as a superior sulcus 
tumor (Rocco et al). 1993;105:944-5 (Letter) 
Right ventricular function; see Ventricular function, right 
Ring abscess; see Abscess 
Risk factors 
Indications, risks, and results of completion pneumonectomy 
(Gregoire etal). 1993;105:918-24 
Relative risk of aortic and femoral insertion of intraaortic balloon 
pump after coronary artery bypass grafting procedures 
(Pinkardetal). 1993;105:721-8 
S 
St. Thomas Hospital cardioplegic solution; see Cardioplegic solu-
tions 
Same-day surgery 
Selection of patients for same-day coronary bypass operations 
(Anderson etal). 1993;105:444-52 
Saphenous vein 
Aneurysm of saphenous vein graft used for aorta-coronary bypass, 
resembling an anterior mediastinal mass (Robicsek et al). 
1993;105:949-51 (Letter) 
The effect of coronary reoperation on the survival of patients with 
stenoses in saphenous vein bypass grafts to coronary arteries 
(Lytle et al). 1993;105:605-14 
Sarcoma, Ewing's 
Medical tumors of the chest wall: solitary plasmacytoma and 
Ewing's sarcoma (Burtetal). 1993;105:89-96 
Size matching; see Organ weight 
Skeletal muscles; see Muscles 
Sling sternal retractor; see Surgical equipment 
Sound spectral analysis; see Spectrum analysis 
Southwest Oncology Group 
Surgical resection of stage IIIA and stage HIB non-small-cell lung 
cancer after concurrent induction chemoradiotherapy: a South-
west Oncology Group trial (Rusch et al). 1993;105:97-106 
Spectrum analysis 
Sound spectral analysis of prosthetic valvular clicks for diagnosis 
of thrombosed Björk-Shiley tilting standard disc valve pros-
theses (Sato et al). 1993;105:313-20 
Staplers; see Surgical staplers 
Statement of appreciation 
Statement of appreciation. 1993; 105:193 
Stomach diseases 
Intrathoracic stomach: presentation and results of operation (Allen 
etal). 1993;105:253-9 
Stroke volume 
Skeletal muscle-powered ventricle: effects of size and configura-
tion on ventricular function (Oda et al). 1993;105:68-77 
Subaortic stenosis; see Aortic valve stenosis 
Subclavian artery 
Aortic aneurysm after subclavian arterial flap angioplasty for co-
arctation of the aorta (Berri et al). 1993; 105:951 (Letter) 
Dysphagia lusoria (Igci et al). 1993; 105:1116-8 (Letter) 
Submammary thoracic perimeter; see Perimetry 
Sub valvular right ventricular outflow tract obstruction; see Ven-
tricular outflow tract obstruction 
Sulcus tumors; see Neoplasms 
Superior vena cava; see Vena cava, superior 
Supravelvular aortic stenosis; see Aortic valve stenosis 
Surgery, methods 
Initial experience with the maze procedure for atrial fibrillation 
(McCarthy et al). 1993; 105:1077-87 
Surgical equipment 
Anatomic lobectomy of the lung by means of thoracoscopy: an ex-
perimental study (Kohno et al). 1993;105:729-31 
A simple and versatile sling sternal retractor for internal mammary 
artery harvesting (Villela de Andrade Vicente). 1993; 105:560-
1 (Letter) 
Surgical flaps 
Aortic aneurysm after subclavian arterial flap angioplasty for co-
arctation of the aorta (Berri et al). 1993; 105:951 (Letter) 
Blunt injury of the innominate artery: use of a vascular pericardial 
flap (Asimacopoulos etal). 1993;105:764-5 (Letter) 
Surgical staplers 
Thoracoscopic stapled resection for spontaneous pneumothorax 
(Hazelrigg etal). 1993;105:389-93 
Surgical wound infection 
Clinical significance of epicardial pacing wire cultures (Hastings 
and Robicsek). 1993;105:165-7 
Survival 
Actuarial five-year survival estimates (Mengoli) (Letter); 
(Dartevelle and Macchiarini) (Reply). 1993;105:375-7 
The effect of coronary reoperation on the survival of patients with 
stenoses in saphenous vein bypass grafts to coronary arteries 
(Lytle et al). 1993;105:605-14 
Endoscopic surveillance of Barrett's esophagus: Does it help? 
(Streitzetal). 1993;105:383-8 
Late results of valve replacement with the Björk-Shiley valve 
(1973 to 1982) (Orszulak et al). 1993;105:302-12 
Repair of truncus arteriosus in the neonate (Hanley et al). 1993; 
105:1047-56 
Results of a policy of primary repair of truncus arteriosus in the ne-
onate (Bove et al). 1993;105:1057-66 
Survival of patients with carcinoma of the esophagus treated with 
combined-modality therapy (Wolfe et al). 1993;105:749-56 
Survival rate 
Bless the babies: one hundred fifteen late survivors of heart trans-
plantation during the first year of life (Bailey et al). 1993; 105: 
805-15 
Clinical experience with the Omnicarbon prosthetic heart valve 
(Misawaetal). 1993;105:168-72 
Systemic flow; see Regional blood flow 
Systole 
Annuloplasty with flexible or rigid ring does not alter left ventric-
ular systolic performance, energetics, or ventricular-arterial 




Experience with an implantable tiered therapy device incorporating 
antitachycardia pacing and cardioverter/defibrillator therapy 
(Mitchell etal). 1993;105:453-63 
Extensive cryoablation of the left ventricular posterior papillary 
muscle and subjacent ventricular wall: impact on mitral valve 
function and hemodynamics (Bakker et al). 1993;105:327-36 
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Talc 
Comparison of insufflated talc under thoracoscopic guidance with 
standard tetracycline and bleomycin pleurodesis for control of 
malignant pleural effusions (Hartman et al). 1993;105:743-8 
Taussig-Bing anomaly 
Intraventricular repair for Taussig-Bing anomaly (Kawashima 
etal). 1993;105:591-7 
Tetracycline 
Comparison of insufflated talc under thoracoscopic guidance with 
standard tetracycline and bleomycin pleurodesis for control of 
malignant pleural effusions (Hartman et al). 1993;105:743-8 
Tetralogy of Fallot 
Tetralogy of Fallot with pulmonary atresia, coronary artery-
pulmonary artery fistula, and origin of left pulmonary artery 
from descending aorta: total correction in infancy (Metras 
etal). 1993;105:186-8 (Letter) 
Thoracic arteries 
Clinical evaluation with exercise performance in twenty patients 
who underwent coronary artery bypass grafting with both the 
gastroepiploic and internal thoracic arteries (Isomura et al). 
1993;105:1088-94 
Dilating effects of isosorbide dinitrate on diameter of internal 
thoracic artery graft (Koike and Kimura). 1993;105:1121-2 
(Letter) 
Thoracic diseases 
Transhiatal esophagectomy for benign and malignant disease 
(Orringer et al). 1993;105:265-77 
Thoracic esophageal diverticulum; see Esophageal diverticulum 
Thoracic neoplasms 
Medical tumors of the chest wall: solitary plasmacytoma and 
Ewing's sarcoma (Burt et al). 1993;105:89-96 
Thoracic perimeter, submammary; see Perimetry 
Thoracic wall necrosis; see Necrosis 
Thoracoabdominal aorta; see Aorta, abdominal; Aorta, thoracic 
Thoracoscopy 
Anatomic lobectomy of the lung by means of thoracoscopy: an ex-
perimental study (Kohno et al). 1993;105:729-31 
Comparison of insufflated talc under thoracoscopic guidance with 
standard tetracycline and bleomycin pleurodesis for control of 
malignant pleural effusions (Hartman et al). 1993;105:743-8 
A new video-assisted thoracoscopic surgical technique for inter-
ruption of patent ductus arteriosus in infants and children 
(Laborde et al). 1993;105:278-80 
Thoracoscopic pleurectomy for treatment of complicated sponta-
neous pneumothorax (Inderbitzi et al). 1993;105:84-8 
Thoracoscopic stapled resection for spontaneous pneumothorax 
(Hazelrigg etal). 1993;105:389-93 
Thoracotomy 
Esophagectomy with or without thoracotomy: Is there any differ-
ence? CTilanus et al). 1993;105:898-903 
Hypotonic cisplatin treatment for carcinomatous pleuritis found at 
thoracotomy in patients with lung cancer: in vitro experiments 
and preliminary clinical results (Ichinose et al). 1993; 105: 
1041-6 
Thoracoscopic stapled resection for spontaneous pneumothorax 
(Hazelrigg etal). 1993;105:389-93 
Thorax 
Anterior transcervical-thoracic approach for radical resection of 
lung tumors invading the thoracic inlet (Dartevelle et al). 
1993;105:1025-34 
N2 lung cancer: outcome in patients with false-negative computed 
tomographic scans of the chest (Daly et al). 1993; 105:904-11 
Thrombectomy; see Thrombosis 
Thrombin 
Immunization by bovine thrombin used with fibrin glue during 
cardiovascular operations: development of thrombin and factor 
V inhibitors (Berruyer et al). 1993;105:892-7 
Plasma levels of endothelin-1 and thrombin-antithrombin I I I com-
plex in patients undergoing open chest operations (Onizuka 
etal). 1993;105:559-60 (Letter) 
Redo cardiac surgery: late bleeding complications from topical 
thrombin-induced factor V deficiency (Cmolik et al). 1993; 
105:222-8 
Thrombosis 
Sound spectral analysis of prosthetic valvular clicks for diagnosis 
of thrombosed Björk-Shiley tilting standard disc valve pros-
theses (Sato et al). 1993;105:313-20 
Successful thrombectomy for thrombosis of the right side of the 
heart after the Fontan operation: report of two cases and review 
of the literature (Hedrick et al). 1993;105:297-301 
Thromboxane A2 
Cardiac-derived thromboxane A2: An initiating mediator of 
reperfusion injury? (Byrne et al). 1993;105:689-93 
Thyroid gland 
Allograft replacement of the trachea: experimental synchronous 
revascularization of composite thyrotracheal transplant 
(Khalil-Marzouk). 1993;105:242-6 
Thyroid hormones 
Reply to invited letter concerning: changes in plasma-free thyroid 
hormones during cardiopulmonary bypass (J T H O R A C C A R -
DIOVASC S U R G 1992;104:526-7) (G0tzsche and Weeke). 1993; 
105:176-8 (Letter) 
Thyrotrachael transplant; see Trachea, transplantation 
Tissue donors 
Improved ultrastructural lung preservation with prostaglandin E i 
as donor pretreatment in a primate model of heart-lung trans-
plantation (Higgins etal). 1993;105:965-71 
Lung size matching for double lung transplantation based on the 
submammary thoracic perimeter: accuracy and functional re-
sults (Massard et al). 1993;105:9-14 
Tissue transplantation 
Acceleration of neointima formation in vascular prostheses by 
transplantation of autologous venous tissue fragments: appli-
cation to small-diameter grafts (Noishiki et al). 1993; 105: 
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